Home > Research Portfolio > by Title

The Title



Title, Institution	Investigator	Award Cycle	Award

2 Top

2010 National Latino Cancer Summit			2010 (Cycle 16)	$25,000
	Latinas Contra Cancer	Duron ,Ysabel
2-D Magnetic Resonance Spectroscopy of Breast Tumors			2001 (Cycle VII)	$62,644
	University of California, Los Angeles	Wyckoff ,Nathaniel

3 Top

3rd Symposium on the Intraductal Approach to Breast Cancer			2003 (Cycle IX)	$25,000
	Dr. Susan Love Research Foundation	Love ,M.D., M.B.A. Susan

4 Top

4th Inter. Symp. on the Intraductal Approach to the Breast			2005 (Cycle 11)	$25,000
	Dr. Susan Love Research Foundation	Love ,M.D., M.B.A. Susan

5 Top

5th International Workshop on Breast Cancer Risk Assessment			2011 (Cycle 17)	$20,000
	University of California, San Francisco	Shepherd ,Ph.D. John

6 Top

6th Symposium on the Intraductal Approach to Breast Cancer			2009 (Cycle 15)	$25,000
	Dr. Susan Love Research Foundation	Mills ,M.D. Dixie

7 Top

7th International Symposium on the Intraductal Approach			2011 (Cycle 17)	$25,000
	Dr. Susan Love Research Foundation	Love ,M.D., M.B.A. Susan

A Top

A Blueprint for Advancing Quality in Breast Cancer			2005 (Cycle 11)	$24,586
	University of California, San Francisco	Esserman ,M.D. Laura
A Candidate Breast Tumor Suppressor Gene on Chromosome 13			1995 (Cycle I)	$305,953
	California Pacific Medical Center Research Institute	Schott ,Ph.D. David
A Candidate Marker of Mammary Tumor Initiating Cells			2006 (Cycle 12)	$284,262
	The Burnham Institute for Medical Research	Terskikh ,Ph.D. Alexey
A Chemical Strategy for Target Discovery in Breast Cancer			2010 (Cycle 16)	$0
	Scripps Research Institute	Cisar ,Ph.D. Justin
A Community-based Workbook for Helping Rural Cancer Patients			1997 (Cycle III)	$58,512
	Stanford University	Koopman ,Ph.D. Cheryl
A Community-Based Workbook for Helping Rural Cancer Patients			1997 (Cycle III)	$46,410
	Sierra Nevada Memorial Hospital Cancer Center	Kreshka ,M.A. Mary Anne
A Genetic System for Identification of Mammary Stem Cells			2009 (Cycle 15)	$76,000
	Salk Institute for Biological Studies	Engle ,BA Dannielle
A Molecular Strategy to Inhibit Breast Cancer Metastasis			2009 (Cycle 15)	$150,000
	University of California, San Francisco	Brodsky ,D.Phil. Frances
A Network-Based Intervention for Chamorros in Southern CA			2001 (Cycle VII)	$59,891
	CSU Fullerton Auxiliary Services Corporation	Tanjasiri ,DrPH, MPH Sora
A Network-Based Intervention for Chamorros in Southern CA			2001 (Cycle VII)	$165,419
	University of California, Irvine	Tanjasiri ,DrPH, MPH Sora
A Network-Based Intervention for Chamorros in Southern CA			2001 (Cycle VII)	$376,796
	Guam Communications Network, Inc.	Sablan Santos ,Lola
A New and Practical PET Detector for Imaging Breast Cancer			1996 (Cycle II)	$69,139
	University of California, Los Angeles	Shao ,Ph.D. Yiping
A New Approach to Immune Therapy for Breast Cancer			1996 (Cycle II)	$204,839
	University of California, Los Angeles	Roth ,M.D. Michael
A New Class of Drugs to Treat Breast Cancer			2000 (Cycle VI)	$33,694
	University of California, San Francisco	Robertson ,Ph.D. Thomas
A New Gene Regulation Factor, LMO-4, in Breast Cancer			1999 (Cycle V)	$134,677
	University of California, San Diego	Andersen ,M.D. Bogi
A New Gene Regulation Factor, LMO-4, in Breast Cancer			1999 (Cycle V)	$54,823
	University of California, Irvine	Andersen ,M.D. Bogi
A New Genetic Vaccine Therapy for Breast Cancer			2001 (Cycle VII)	$100,000
	University of California, Irvine	Nelson ,M.D. Edward
A New Marker for Mammary Epithelial Stem Cells?			2006 (Cycle 12)	$188,827
	The Burnham Institute for Medical Research	Oshima ,Ph.D. Robert
A New Model for Inflammatory Breast Carcinoma			1999 (Cycle V)	$200,000
	University of California, Los Angeles	Barsky ,M.D. Sanford
A New Mouse Model of PI3-Kinase Induced Breast Cancer			2007 (Cycle 13)	$89,600
	University of California, San Francisco	Zhang ,Ph.D., M.D. Jun
A New Radiotracer for Sentinel Node Imaging of Breast Cancer			1996 (Cycle II)	$27,183
	University of California, San Diego	Vera ,Ph.D. David
A New Radiotracer for Sentinel Node Imaging of Breast Cancer			1996 (Cycle II)	$105,782
	University of California, Davis	Vera ,Ph.D. David
A New System for Breast Cancer Drug Delivery			1998 (Cycle IV)	$73,185
	California Pacific Medical Center Research Institute	Drummond ,Ph.D. Daryl
A Non-Invasive Method of Locating Malignant Breast Tumors			1995 (Cycle I)	$189,421
	University of California, Los Angeles	Hoffman ,Ph.D. Edward
A Novel Anti-estrogen Resistance Mechanism in Breast Cancer			2002 (Cycle VIII)	$143,250
	The Burnham Institute for Medical Research	Ely ,Ph.D. Kathryn
A Novel Antigen Associated with Breast Cancer Metastasis			2000 (Cycle VI)	$135,132
	Sidney Kimmel Cancer Center	Testa ,Ph.D. Jacqueline
A Novel Approach to Inactivate the Estrogen Receptor			2004 (Cycle 10)	$60,000
	University of California, San Francisco	So ,BA Alex
A Novel Biological Framework for the Role of Xenoestrogens			2006 (Cycle 12)	$279,242
	California Pacific Medical Center Research Institute	Dairkee ,Ph.D. Shanaz
A Novel Drug Induces Apoptosis in Breast Cancer Cells			1998 (Cycle IV)	$228,595
	Stanford University	Rosen ,M.D. Glenn
A Novel Epithelial-Stromal Model of Metastatic Breast Cancer			2005 (Cycle 11)	$205,716
	Lawrence Berkeley National Laboratory	Neve ,Ph.D. Richard
A Novel Gene Associated With an Altered Risk of Breast Cance			1998 (Cycle IV)	$373,725
	University of California, Berkeley	Nandi ,Ph.D. Satyabrata
A Novel Mediator of AI Resistance in Breast Cancer			2010 (Cycle 16)	$76,000
	Beckman Research Institute of the City of Hope	Petrossian ,M.S. Karineh
A Novel Predictive Test for Her-2/EGFR Ab-based Therapeutics			2003 (Cycle IX)	$79,600
	University of California, San Francisco	Kallab ,M.D. Verena
A Novel Signal Transduction Pathway in Breast Cancer			2000 (Cycle VI)	$79,981
	University of California, San Diego	Cao ,Ph.D., M.D. Yixue
A Patient Decision Support Framework for Breast Cancer			2000 (Cycle VI)	$148,400
	University of California, San Francisco	Hunt ,Ph.D. C. Anthony
A Peptide Vaccine for Breast Cancer Prevention			1995 (Cycle I)	$85,349
	Epimmune Inc.	Sette ,Ph.D. Alessandro
A Peptide Vaccine for Breast Cancer Prevention			1995 (Cycle I)	$304,385
	Cytel Corporation	Sette ,Ph.D. Alessandro
A Predictive Factor for Eribulin Treatment of Breast Cancer			2009 (Cycle 15)	$75,500
	University of California, Santa Barbara	Smith ,B.S. Jennifer
A Role for p53 and Splicing Factor SAP145 in Breast Cancer			2005 (Cycle 11)	$76,000
	University of California, Irvine	Truong ,B.S. Lan
A Role for RAD51B in Breast Cancer			1999 (Cycle V)	$406,092
	Lawrence Livermore National Laboratory	Albala ,Ph.D. Joanna
A Study of the Molecular Heterogeneity of LCIS			2000 (Cycle VI)	$150,000
	University of California, Los Angeles	Barsky ,M.D. Sanford
A Support Group Alternative for Rural and Isolated Women			1999 (Cycle V)	$588,328
	Stanford University	Koopman ,Ph.D. Cheryl
A Support Group Alternative for Rural and Isolated Women			1999 (Cycle V)	$588,328
	Stanford University	Kreshka ,M.A. Mary Anne
A Targeted Therapy for Wound-like Breast Cancers			2006 (Cycle 12)	$232,934
	Stanford University	Chang ,M.D, Ph.D. Howard
A Vascular Restriction of Mammary Tumor Progression			2000 (Cycle VI)	$384,466
	The Burnham Institute for Medical Research	Oshima ,Ph.D. Robert
Abnormal Regulation in Breast Cancer Development/Metastasis			1996 (Cycle II)	$516,413
	Scripps Research Institute	Knaus ,Ph.D. Ulla
Activity Based Profiling of Breast Cancer Xenografts			2003 (Cycle IX)	$30,000
	Scripps Research Institute	Jessani ,B.S. Nadim
ACTR/A1B1 in Mammary Gland Development and Tumorigenesis			1999 (Cycle V)	$16,178
	Salk Institute for Biological Studies	Xie ,M.D., Ph.D. Wen
Adapting a Breast Cancer Education Program for South Asians			2008 (Cycle 14)	$163,749
	University of California, Los Angeles	Surani ,B.S. Zul
Adapting a Breast Cancer Education Program for South Asians			2008 (Cycle 14)	$163,749
	University of California, Los Angeles	Glenn ,Ph.D. Beth
Addressing Cultural & Tribal Issues in Breast Cancer			2006 (Cycle 12)	$79,100
	University of California, Davis	von Friederichs-Fitzwater,Ph.D. Marlene
Addressing Cultural & Tribal Issues in Breast Cancer			2006 (Cycle 12)	$87,875
	Turtle Health Foundation	Navarro ,Linda
African American Women and Breast Cancer: What Works?			2002 (Cycle VIII)	$131,244
	Kaiser Foundation Research Institute	Somkin ,Ph.D. Carol
African American Women and Breast Cancer: What Works?			2002 (Cycle VIII)	$131,244
	Kaiser Foundation Research Institute	Banks ,M.A. Priscilla
Alcohol Intake & Risk of Estrogen-Receptor Positive Br Ca			1995 (Cycle I)	$73,996
	University of Southern California	Enger ,Ph.D. Shelley
Alteration of Developmental Genes in Breast Cancer			1998 (Cycle IV)	$292,500
	The Burnham Institute for Medical Research	Yamamoto ,Ph.D. Fumiichiro
Alteration of Dietary Fat To Reduce Breast Cancer Metastasis			1995 (Cycle I)	$290,950
	University of California, Davis	Erickson ,Ph.D. Kent
Altering telomerase to prevent breast cancer progression			1996 (Cycle II)	$44,677
	University of California, San Francisco	Blackburn ,Ph.D. Elizabeth
Alternative pre-mRNA Splicing in Mammary Epithelial Cells			2003 (Cycle IX)	$119,968
	Lawrence Berkeley National Laboratory	Conboy ,Ph.D. John
An Approach to Antiestrogen Resistance in Breast Cancer			2005 (Cycle 11)	$132,860
	University of California, San Diego	Tyurina ,Ph.D. Oksana
An Ecological Study of Quality of Life in Low-Income Women			2008 (Cycle 14)	$0
	University of California, Los Angeles	Umezawa ,Ph.D. Yoshiko
Analogs of tea polyphenols for breast cancer chemoprevention			1996 (Cycle II)	$429,092
	SRI International	Zaveri ,Ph.D. Nurulain
Analysis of a New Human Caspase in Breast Cancer			2000 (Cycle VI)	$51,527
	The Burnham Institute for Medical Research	Lee ,M.D., Ph.D. Sug Hyung
Analysis of a Protease Involved in Mammary Development			2001 (Cycle VII)	$79,595
	Lawrence Berkeley National Laboratory	Zahedi ,Ph.D. Rana
Analysis of Angiogenic Pathways in Metastatic Breast Cancer			2000 (Cycle VI)	$86,400
	The Burnham Institute for Medical Research	Hindmarsh ,Ph.D. Elizabeth
Analysis of EGFR Transcript Splicing in C. Elegans			2002 (Cycle VIII)	$86,400
	California Institute of Technology	Van Buskirk ,Ph.D. Cheryl
Analysis of Genes Predictive of Breast Cancer Metastasis			2000 (Cycle VI)	$221,925
	University of California, Davis	Gregg ,M.D. Jeffrey
Analysis of MicroRNA Expression in Breast Cancer Stem Cells			2006 (Cycle 12)	$134,976
	Stanford University	Shimono ,M.D., Ph.D. Yohei
Analysis of Rac Mutations in Breast Cancer			1997 (Cycle III)	$87,413
	Scripps Research Institute	Jackson ,M.D. Janis
Androgen Receptor Gene and p21 Gene in Breast Cancer			2005 (Cycle 11)	$34,293
	University of Southern California	Wang ,M.D. Wei
Androgen Receptor Gene and PSA Gene in Breast Cancer Risk			2002 (Cycle VIII)	$59,557
	University of Southern California	Wang ,M.D. Wei
Angiogenesis in Hyperplasia to In-Situ Breast Cancers			2003 (Cycle IX)	$250,000
	University of California, Irvine	Su ,Ph.D. Min-Ying (Lydia)
Antibody Fusion Proteins for the Therapy of Breast Cancer			1997 (Cycle III)	$193,224
	University of California, Los Angeles	Morrison ,Ph.D. Sherie
Antibody-based Targeting of Breast Cancer Stem Cells			2009 (Cycle 15)	$150,000
	University of California, Santa Barbara	Gottstein ,M.D. Claudia
Antibody-IL-2 Fusion Protein for Breast Cancer Immunotherapy			1998 (Cycle IV)	$419,144
	Sidney Kimmel Cancer Center	Lustgarten ,Ph.D. Joseph
Anti-breast cancer activity of vitamin A derivatives			1996 (Cycle II)	$76,126
	The Burnham Institute for Medical Research	Agadir ,Ph.D. Anissa
Antidepressants and Breast Cancer Treatment Interactions			2008 (Cycle 14)	$156,068
	Kaiser Foundation Research Institute	Haque ,Ph.D. Reina
Anti-E-Cadherin Apoptosis of Inflammatory Breast Carcinoma			2000 (Cycle VI)	$80,000
	University of California, Los Angeles	Alpaugh ,Ph.D. Mary
Apaf-1 is a Transcriptional Target for the ZNF217 Oncogene			2005 (Cycle 11)	$53,649
	University of California, Davis	Krig ,Ph.D. Sheryl
Apogossypol Derivatives for Breast Cancer Therapy			2004 (Cycle 10)	$285,764
	The Burnham Institute for Medical Research	Pellecchia ,Ph.D. Maurizo
APOS 5th Annual Conference			2008 (Cycle 14)	$15,000
	University of California, Los Angeles	Ganz ,M.D. Patricia
Architecture of the ErbB2 Molecule Leading to Breast Cancer			1996 (Cycle II)	$222,349
	University of California, San Francisco	Marks ,Ph.D. Cara
Are EGF-Receptors Activated by IL-8 in Breast Cancer?			2001 (Cycle VII)	$155,475
	La Jolla Institute for Molecular Medicine	Schraufstatter ,M.D. Ingrid
Arginine Deiminase as an Innovative Anti-Breast Cancer Agent			2000 (Cycle VI)	$81,507
	University of Southern California	Shen ,Ph.D. Wei-Chiang
'Art for Recovery': Expanding Access for the Underserved			2003 (Cycle IX)	$83,368
	Stanford University	Collie ,Ph.D. Kate
Artemisinin Disrupts Estrogen Receptor-Alpha and Cell Growth			2006 (Cycle 12)	$100,000
	University of California, Berkeley	Firestone ,Ph.D. Gary
Assessing Recurrent Genomic Aberrations Linked to Ethnicity			2004 (Cycle 10)	$100,000
	University of California, San Francisco	Chin ,M.D., Ph.D. Koie
Assessing the Impact of Shame and Guilt in Recovery			2003 (Cycle IX)	$152,094
	Stanford University	Giese-Davis ,Ph.D. Janine
At-Home Group Video Calling to Support Rural Women			2011 (Cycle 17)	$94,800
	Stanford University	Koopman ,Ph.D. Cheryl
At-Home Group Video Calling to Support Rural Women			2011 (Cycle 17)	$112,500
	Sierra Streams Institute	Kreshka ,M.A. Mary Anne
At-Home Group Video Calling to Support Rural Women			2011 (Cycle 17)	$112,500
	Sierra Streams Institute	Hild ,M.S. Zoology Joanne
Autoantibodies in Breast Cancer			1997 (Cycle III)	$130,130
	Scripps Research Institute	Ochs ,Ph.D. Robert
Axon Guidance Proteins in Mammary Gland Development			2004 (Cycle 10)	$449,228
	University of California, Santa Cruz	Hinck ,Ph.D. Lindsay

B Top

Bax gene expression in breast cancer			1995 (Cycle I)	$559,057
	The Burnham Institute for Medical Research	Reed ,M.D., Ph.D. John
BCT.org: Feasibility of a Clinical Trial Matching Tool			2003 (Cycle IX)	$99,200
	University of California, San Francisco	Park ,M.D. John
BCT.org: Feasibility of a Clinical Trial Matching Tool			2003 (Cycle IX)	$99,200
	University of California, San Francisco	Lieberman ,Ph.D. Morton
Beliefs and Risks of Breast Cancer Among African Immigrants			1999 (Cycle V)	$236,853
	University of California, San Francisco	Beyene ,Ph.D. Yewoubdar
Benign Breast Disease, Biopsy & Cancer Preventive Self-Care			1995 (Cycle I)	$224,351
	University of California, Davis	O'Connor ,Ph.D. Jacqueline
Biochemical and Functional Characterization of BRCA1			1998 (Cycle IV)	$75,445
	Salk Institute for Biological Studies	Ruffner ,Ph.D. Heinz
Biochemical Correlates for Clinical Response to Paclitaxel			1997 (Cycle III)	$110,390
	University of Southern California	Formenti ,M.D. Silvia
Biologic Determinants of Response to Paclitaxel & Radiation			1998 (Cycle IV)	$595,661
	University of Southern California	Formenti ,M.D. Silvia
Biologic Determinants of Response to Paclitaxel & Radiation			1998 (Cycle IV)	$595,661
	University of Southern California	Danenberg ,Ph.D. Peter
Biologic Determinants of Response to Paclitaxel & Radiation			1998 (Cycle IV)	$595,661
	University of Southern California	Muggia ,M.D. Franco
Biological Determinants of Response to Paclitaxel and Radiat			1998 (Cycle IV)	$0
	Molecular Medicine Research Institute	Danenberg ,Ph.D. Peter
Biological Determinants of Response to Paclitaxel and Radiat			1998 (Cycle IV)	$0
	Molecular Medicine Research Institute	Muggia ,M.D. Franco
Biologically relevant screening of endocrine disruptors			2011 (Cycle 17)	$1,512,000
	Beckman Research Institute of the City of Hope	Chen ,Ph.D. Shiuan
Biology of Telomere Length Conservation in Breast Cancer			1995 (Cycle I)	$78,798
	University of Southern California	Shibata ,M.D. Darryl
Biomarkers for environmental exposures in breast cancer			2011 (Cycle 17)	$900,000
	University of California, San Francisco	Werb ,Ph.D. Zena
Birth Characteristics and Breast Cancer in Young Women			2004 (Cycle 10)	$212,553
	Impact Assessment, Inc.	Reynolds ,Ph.D. Peggy
Birth Characteristics and Breast Cancer in Young Women			2004 (Cycle 10)	$690,586
	Cancer Prevention Institute of California	Reynolds ,Ph.D. Peggy
Bispecific Antibodies for Radiotherapy of Breast Cancer			1999 (Cycle V)	$68,615
	University of California, Davis	Winthrop ,Ph.D. Michelle
Blocking Breast Cancer Progression with Radioactive Antibody			1995 (Cycle I)	$50,000
	University of California, Irvine	Samoszuk ,M.D. Michael
Blocking Stromelysin-3 to Inhibit Breast Cancer Metastasis			1997 (Cycle III)	$358,783
	SRI International	Zaveri ,Ph.D. Nurulain
Blood Vessel Markers in Breast Cancer			2001 (Cycle VII)	$378,655
	The Burnham Institute for Medical Research	Ruoslahti ,M.D., Ph.D. Erkki
Bovine Leukemia Virus and Human breast Cancer Risk			1997 (Cycle III)	$150,000
	University of California, Berkeley	Buehring ,Ph.D. Gertrude
Bovine leukemia virus and human breast cancer risk			1996 (Cycle II)	$50,000
	University of California, Berkeley	Buehring ,Ph.D. Gertrude
Bovine Leukemia Virus and Mammary Cell Infection			1997 (Cycle III)	$69,981
	University of California, Berkeley	Kingsbury ,Ph.D. Linda
Bovine Leukemia Virus Infection and Human Breast Cancer Risk			2000 (Cycle VI)	$187,414
	University of California, Berkeley	Buehring ,Ph.D. Gertrude
BRCA1 regulation in breast cancer: a rat mammary model			1996 (Cycle II)	$368,159
	University of Southern California	Williams-Hill ,Ph.D. Donna
BRCA1-dependent Ubiquitin Ligase Activity in Breast Cancer			2002 (Cycle VIII)	$65,297
	Salk Institute for Biological Studies	Xia ,Ph.D. Yan
Breast Cancer & Chemicals Policy			2009 (Cycle 15)	$234,739
	University of California, Berkeley	Schwarzman ,MD, MPH Megan
Breast Cancer and Genetic Differences in Estrogen Formation			1996 (Cycle II)	$81,598
	University of Southern California	Probst-Hensch ,Ph.D. Nicole
Breast Cancer Cell Binding to the Endothelium			1999 (Cycle V)	$326,892
	Scripps Research Institute	Felding-Habermann ,Ph.D. Brunhilde
Breast Cancer Chemoprevention by Retinoids			1997 (Cycle III)	$967,300
	The Burnham Institute for Medical Research	Zhang ,Ph.D. Xiao-Kun
Breast Cancer Chemoprevention by Vitamin D Plus Retinoids			1995 (Cycle I)	$0
	Molecular Medicine Research Institute	Dawson ,Ph.D. Marcia
Breast Cancer Chemoprevention by Vitamin D Plus Retinoids			1995 (Cycle I)	$466,049
	SRI International	Dawson ,Ph.D. Marcia
Breast Cancer Chemoprevention with Dietary Herbal Estrogens			2004 (Cycle 10)	$199,310
	University of California, San Francisco	Leitman ,M.D., Ph.D. Dale
Breast Cancer Chemotherapy: Does It Impair Brain Function?			1995 (Cycle I)	$307,456
	California School of Professional Psychology	Wieneke ,Ph.D. Mary
Breast Cancer Clinical Trials Education Program			2008 (Cycle 14)	$158,140
	University of California, San Diego	Sadler ,Ph.D. M.B.A. Georgia
Breast Cancer Clinical Trials Education Program			2008 (Cycle 14)	$364,970
	Vista Community Clinic	Riley ,M.A. Natasha
Breast Cancer Clinical Trials Education Program			2008 (Cycle 14)	$208,657
	San Diego State University	Malcarne ,Ph.D. Vanessa
Breast Cancer Education for Deaf and Hard-of-Hearing Women			2006 (Cycle 12)	$375,000
	Greater Los Angeles Council on Deafness, Inc.	Booth ,B.S. Heidi
Breast Cancer Education for Deaf and Hard-of-Hearing Women			2006 (Cycle 12)	$295,494
	University of California, Los Angeles	Berman ,Ph.D. Barbara
Breast Cancer Functional Imaging with Optics and MRI			2004 (Cycle 10)	$500,000
	University of California, Irvine	Tromberg ,Ph.D. Bruce
Breast Cancer Functional Imaging with Optics and MRI			2004 (Cycle 10)	$500,000
	University of California, Irvine	Butler ,M.D. John
Breast Cancer Functional Imaging with Optics and MRI			2004 (Cycle 10)	$500,000
	University of California, Irvine	Hylton ,Ph.D. Nola
Breast Cancer Gene Expression Using Amplified Core Biopsies			1999 (Cycle V)	$155,286
	Stanford University	Jeffrey ,M.D. Stefanie
Breast Cancer Gene Therapy Using a Metastasis Inhibitor			1997 (Cycle III)	$75,599
	University of Southern California	Zhou ,M.D., Ph.D Qing
Breast Cancer Imaging by 2-D Magnetic Resonance Spectroscopy			2001 (Cycle VII)	$248,762
	University of California, Los Angeles	Thomas ,Ph.D. Michael Albert
Breast Cancer Immunotherapy Using CD4+ Lymphocytes			1998 (Cycle IV)	$43,289
	University of California, San Diego	Mitchell ,M.D. Malcolm
Breast Cancer in California Teachers- Regional Variations			2000 (Cycle VI)	$160,267
	Public Health Institute	Reynolds ,Ph.D. Peggy
Breast Cancer Incidence in California Flight Attendants			1997 (Cycle III)	$56,922
	Public Health Institute	Reynolds ,Ph.D. Peggy
Breast Cancer Incidence in Women with Abnormal Cytology			1995 (Cycle I)	$329,176
	University of California, San Francisco	Wrensch ,M.P.H., Ph.D. Margaret
Breast Cancer Knowledge/Attitudes:So. Cal. Pacific Islanders			1997 (Cycle III)	$70,000
	University of California, Irvine	Tanjasiri ,DrPH, MPH Sora
Breast Cancer Lymphedema: Role of Insulin Resistance/FOXC2			2005 (Cycle 11)	$234,071
	Stanford University	Rockson ,M.D. Stanley
Breast Cancer Markers and Response to Adjuvant Therapy			1998 (Cycle IV)	$0
	Kaiser Foundation Research Institute	Press ,M.D., Ph.D. Michael
Breast Cancer Metastasis: a Heritable Trait?			2006 (Cycle 12)	$264,595
	Stanford University	Whittemore ,Ph.D., M.A. Alice
Breast Cancer Neoadjuvant Chemotherapy Response with miRNA			2010 (Cycle 16)	$249,000
	Beckman Research Institute of the City of Hope	Wang ,Ph.D. Shizhen Emily
Breast Cancer Prevention and Control Among Deaf Women			2001 (Cycle VII)	$110,015
	University of California, Los Angeles	Berman ,Ph.D. Barbara
Breast Cancer Prevention and Control Among Deaf Women			2001 (Cycle VII)	$110,015
	University of California, Los Angeles	Booth ,B.S. Heidi
Breast Cancer Prevention by Analogs of EGCG from Green Tea			2000 (Cycle VI)	$296,115
	SRI International	Zaveri ,Ph.D. Nurulain
Breast Cancer Prevention by Inhibition of Estrogen Action			1999 (Cycle V)	$302,983
	Cedars-Sinai Medical Center	Davis ,Ph.D. Vicki
Breast Cancer Prevention with Estrogen			2002 (Cycle VIII)	$812,340
	University of California, Berkeley	Nandi ,Ph.D. Satyabrata
Breast Cancer Prevention with Phytochemicals in Mushrooms			2004 (Cycle 10)	$759,667
	Beckman Research Institute of the City of Hope	Chen ,Ph.D. Shiuan
Breast Cancer Prevention with Phytoestrogens in Grape Juice			1998 (Cycle IV)	$539,331
	Beckman Research Institute of the City of Hope	Chen ,Ph.D. Shiuan
Breast Cancer Prevention: The Views of Women and Physicians			2000 (Cycle VI)	$434,559
	University of California, San Francisco	Kaplan ,DrPH Celia
Breast Cancer Progression and the Extracellular Matrix			1995 (Cycle I)	$493,643
	University of Southern California	Markland ,Ph.D. Francis
Breast Cancer Risk Associated with High Mammographic Density			2005 (Cycle 11)	$148,163
	University of California, San Francisco	Tlsty ,Ph.D. Thea
Breast Cancer Risk Factors and Hormone Receptors			1996 (Cycle II)	$271,408
	Kaiser Foundation Research Institute	Geiger ,M.P.H., Ph.D. Ann
Breast Cancer Risk Factors: Lesbian & Heterosexual Women			1997 (Cycle III)	$23,991
	Lyon-Martin Women's Health Services	Roberts ,M.D. Stephanie
Breast Cancer Risk Factors: Lesbian & Heterosexual Women			1997 (Cycle III)	$31,943
	University of California, San Francisco	Dibble ,D.N.Sc., RN Suzanne
Breast Cancer Risk Factors: Lesbian and Heterosexual Women			1998 (Cycle IV)	$169,423
	Lyon-Martin Women's Health Services	Roberts ,M.D. Stephanie
Breast Cancer Risk Factors: Lesbian and Heterosexual Women			1998 (Cycle IV)	$186,214
	University of California, San Francisco	Dibble ,D.N.Sc., RN Suzanne
Breast Cancer Risk Profile of Vietnamese Nail Salon Workers			2005 (Cycle 11)	$7,393
	Impact Assessment, Inc.	Reynolds ,Ph.D. Peggy
Breast Cancer Risk Profile of Vietnamese Nail Salon Workers			2005 (Cycle 11)	$44,798
	Cancer Prevention Institute of California	Reynolds ,Ph.D. Peggy
Breast Cancer Risk Profile of Vietnamese Nail Salon Workers			2005 (Cycle 11)	$67,322
	Asian Health Services	Nguyen ,Kim
Breast Cancer Risk Reduction in American Indian Women			2008 (Cycle 14)	$10,000
	The Regents of the University of California	von Friederichs-Fitzwater,Ph.D. Marlene
Breast Cancer Risk Reduction in American Indian Women			2008 (Cycle 14)	$10,000
	The Regents of the University of California	Navarro ,Linda
Breast Cancer Risk Reduction: A Patient-Doctor Intervention			2009 (Cycle 15)	$740,690
	University of California, San Francisco	Kaplan ,DrPH Celia
Breast Cancer Risks in California Nail Salon Workers			2007 (Cycle 13)	$349,303
	Cancer Prevention Institute of California	Reynolds ,Ph.D. Peggy
Breast Cancer Risks in California Nail Salon Workers			2007 (Cycle 13)	$317,610
	Asian Health Services	Okahara ,Linda
Breast Cancer Screening in Women Surviving Hodgkin's Disease			1999 (Cycle V)	$1,033,898
	Stanford University	Hancock ,M.D. Steven
Breast Cancer Studies in a 3-D Cell Culture System			2005 (Cycle 11)	$188,602
	The Burnham Institute for Medical Research	Vuori ,M.D., Ph.D. Kristiina
Breast Cancer Survivorship: Partner's Role in Recovery			1999 (Cycle V)	$610,760
	University of Southern California	Meyerowitz ,Ph.D. Beth
Breast Cancer Susceptibility Genes in Very High Risk Women			1999 (Cycle V)	$129,247
	University of Southern California	Hamilton ,Ph.D. Ann
Breast Cancer Treatment Monitoring Combining MRI and Optics			2007 (Cycle 13)	$113,166
	University of California, San Francisco	Klifa ,Ph.D. Catherine
Breast Cancer Tumor-Stroma Interactions in an In Vivo Model			2009 (Cycle 15)	$284,250
	Vaccine Research Institute of San Diego	Borgstrom ,Ph.D. Per
Breast Cancer-secreted MicroRNAs in the Pre-metastatic Niche			2011 (Cycle 17)	$252,000
	Beckman Research Institute of the City of Hope	Wang ,Ph.D. Shizhen Emily
Breast Carcinoma Associated MAR-binding Proteins p90 and p70			1997 (Cycle III)	$69,998
	Lawrence Berkeley National Laboratory	Galande ,Ph.D. Sanjeev
Breast CT for Much Earlier Detection of Breast Cancer			2001 (Cycle VII)	$500,000
	University of California, Davis	Boone ,Ph.D. John
Breast CT for Much Earlier Detection of Breast Cancer			2001 (Cycle VII)	$500,000
	University of California, Davis	Lindfors ,M.D. Karen
Breast Health Behaviors of Immigrant Afghan Women			2007 (Cycle 13)	$70,285
	University of California, Berkeley	Bloom ,Ph.D. Joan
Breast Health Behaviors of Immigrant Afghan Women			2007 (Cycle 13)	$99,125
	Afghan Coalition	Shirazi ,Aida
Breast Health Literacy and Health Care Decision Making			2006 (Cycle 12)	$3,964
	San Diego State University Research Foundation	Lindsay ,Ph.D., MSW, MPH Suzanne
Breast Health Literacy and Health Care Decision Making			2006 (Cycle 12)	$6,000
	Operation Samahan Inc.	San Juan ,M.S. Joel
Breast Health Project for Hmong Women and Men			1999 (Cycle V)	$496,322
	University of California, Los Angeles	Kagawa-Singer ,Ph.D., R.N., M.N., M.A. Marjorie
Breast Health Project for Hmong Women and Men			1999 (Cycle V)	$496,322
	University of California, Los Angeles	Foo ,M.P.H., CHES Mary Anne
Breast Screening Program in the Hmong American Community			1997 (Cycle III)	$74,250
	University of California, Los Angeles	Kagawa-Singer ,Ph.D., R.N., M.N., M.A. Marjorie
Breast Stromal Genes Act as Early Markers of Malignancy			2002 (Cycle VIII)	$398,072
	Stanford University	Jeffrey ,M.D. Stefanie
Breast Stromal Genes Act as Early Markers of Malignancy			2002 (Cycle VIII)	$398,072
	Stanford University	Tlsty ,Ph.D. Thea
Breast Stromal Genes Act as Early Markers of Malignancy			2002 (Cycle VIII)	$249,624
	University of California, San Francisco	Jeffrey ,M.D. Stefanie
Breast Stromal Genes Act as Early Markers of Malignancy			2002 (Cycle VIII)	$249,624
	University of California, San Francisco	Tlsty ,Ph.D. Thea
Breast Tumor Inhibition by Vitamin D in a Mouse Model			2006 (Cycle 12)	$234,388
	Stanford University	Feldman ,M.D. David
Breast Tumor Markers and Response to Adjuvant Therapy			1998 (Cycle IV)	$0
	Kaiser Foundation Research Institute	Greif ,M.D. Jon
Breast Tumor Markers and Response to Adjuvant Therapy			1998 (Cycle IV)	$77,327
	Kaiser Foundation Research Institute	Enger ,Ph.D. Shelley
Breast Tumor Responses to Novel TGF-beta Inhibitors			2007 (Cycle 13)	$60,521
	University of California, San Francisco	Harradine ,Ph.D. Kelly
Building on National Initiatives for New Chemicals Screening			2011 (Cycle 17)	$1,175,569
	University of California, Berkeley	Vulpe ,Ph.D. Chris

C Top

Cadmium, Age at Menarche, and Early Puberty in Girls			2011 (Cycle 17)	$206,312
	Cancer Prevention Institute of California	Rull ,Ph.D. Rudolph
California Breast Cancer Survivorship Consortium - USC AABCS			2010 (Cycle 16)	$1,007,117
	University of Southern California	Wu ,Ph.D. Anna
cAMP Antagonists of Protein Kinase as Breast Cancer Drugs			2005 (Cycle 11)	$28,404
	University of California, San Diego	Saldanha ,Ph.D. Sanjay Adrian
cAMP Antagonists of Protein Kinase as Breast Cancer Drugs			2005 (Cycle 11)	$48,253
	Scripps Research Institute	Saldanha ,Ph.D. Sanjay Adrian
Can Molecular Markers Predict Response to Adjuvant Therapy			1999 (Cycle V)	$260,545
	Kaiser Foundation Research Institute	Enger ,Ph.D. Shelley
Can Molecular Markers Predict Response to Adjuvant Therapy?			1999 (Cycle V)	$508,813
	University of Southern California	Press ,M.D., Ph.D. Michael
Can Placenta Factors Explain Race Patterns of Breast Cancer?			2002 (Cycle VIII)	$84,502
	Public Health Institute	Cohn ,Ph.D., MPH, MCP Barbara
Cancer and Complexity: Questions for a New Millenium			2000 (Cycle VI)	$11,760
	Lawrence Berkeley National Laboratory	Barcellos-Hoff ,Ph.D. Mary Helen
Cancer and Complexity: Questions for a New Millenium			2000 (Cycle VI)	$11,760
	Lawrence Berkeley National Laboratory	Harris ,Ph.D. G. Shyamala
Cancer and Complexity: Questions for a New Millenium			2000 (Cycle VI)	$11,760
	Lawrence Berkeley National Laboratory	Bissell ,Ph.D. Mina
Cancer Mapping: Making Spatial Models Work for Communities			2009 (Cycle 15)	$349,225
	Public Health Institute	Roberts ,M.D., Ph.D. Eric
Case-Control Study of Breast Cancer in Asian-American Women			1995 (Cycle I)	$639,651
	University of Southern California	Wu ,Ph.D. Anna
Caspase-mediated Apoptosis Mechanisms in Breast Cancer Cells			2002 (Cycle VIII)	$60,000
	The Burnham Institute for Medical Research	Boatright ,B.S. Kelly
CBCSC - City of Hope			2010 (Cycle 16)	$435,775
	Beckman Research Institute of the City of Hope	Bernstein ,Ph.D. Leslie
CBCSC - CPIC			2010 (Cycle 16)	$680,585
	Cancer Prevention Institute of California	Gomez ,PhD Scarlett
CBCSC - Kaiser DOR			2010 (Cycle 16)	$491,085
	Kaiser Foundation Research Institute	Kwan ,Ph.D. Marilyn
CBCSC - USC MEC			2010 (Cycle 16)	$216,689
	University of Southern California	Monroe ,Ph.D. Kristine
Cell Adhesion and Drug Resistance in Breast Cancer			2000 (Cycle VI)	$190,773
	The Burnham Institute for Medical Research	Vuori ,M.D., Ph.D. Kristiina
Cell Adhesion Signaling Defects in Breast Cancer			1998 (Cycle IV)	$26,841
	The Burnham Institute for Medical Research	Zeh ,Ph.D. Karin
Cell bioassays for detection of aromatase gene activators			2011 (Cycle 17)	$421,680
	University of California, Davis	Denison ,Ph.D. Michael
Cell Growth Control of Breast Epithelial Cells			2000 (Cycle VI)	$265,950
	Scripps Research Institute	Knaus ,Ph.D. Ulla
Cell Microenvironment and Progression of Breast Cancer			1995 (Cycle I)	$66,048
	Lawrence Berkeley National Laboratory	Lochter ,Ph.D. Andre
Cell-Based Immunotherapy for Breast Cancer			2000 (Cycle VI)	$120,811
	University of California, San Francisco	Jabrane-Ferrat ,Ph.D. Nabila
Cell-Killing Effect of Orphan Receptor TR3 in Breast Cancer			2002 (Cycle VIII)	$84,643
	The Burnham Institute for Medical Research	Bruey-Sedano ,Ph.D. Nathalie
Changes in Transport into the Nucleus in Breast Cancer			1995 (Cycle I)	$5,047
	Scripps Research Institute	Sweet ,Ph.D. Deborah
Characterization of hAG-2 and Its Role in Breast Cancer			1999 (Cycle V)	$166,465
	Stanford University	Thompson ,M.Sc., Ph.D. Devon
Characterization of Heregulin Targeted Genes			1997 (Cycle III)	$22,115
	Lawrence Berkeley National Laboratory	Guerra-Vladusic ,Ph.D. Fabiana
Characterizing Breast Cancer Cells in Blood and Bone Marrow			2004 (Cycle 10)	$155,781
	Stanford University	Carlson ,M.D. Robert
Chemerin as an Immunotherapeutic Agent in Breast Cancer			2009 (Cycle 15)	$89,600
	Palo Alto Institute for Research & Education	Pachynski ,M.D. Russell
Chemical Inhibitors of Hsp70 for Breast Cancer			2006 (Cycle 12)	$103,232
	The Burnham Institute for Medical Research	Shiau ,Ph.D. Chung-Wai
Chemokine Receptor Signaling in Breast Cancer			2008 (Cycle 14)	$74,660
	University of California, San Diego	O'Hayre ,B.S. Morgan
Chemotherapy-Induced Ovarian Damage: Prevention and Impact			2002 (Cycle VIII)	$64,189
	University of California, San Francisco	Berlin ,M.S. Lucy
Chemotherapy-Induced Ovarian Damage: Prevention and Impact			2002 (Cycle VIII)	$64,189
	University of California, San Francisco	Rugo ,M.D. Hope
Chemotherapy-Induced Ovarian Damage: Prevention and Impact			2002 (Cycle VIII)	$82,027
	Stanford University	Westphal ,M.D. Lynn
Child's Stress During Mother's Treatment for Breast Cancer			2001 (Cycle VII)	$127,553
	California Pacific Medical Center Research Institute	Levine ,Ph.D., M.P.H. Ellen
Child's Stress During Mother's Treatment for Breast Cancer			2001 (Cycle VII)	$127,553
	California Pacific Medical Center Research Institute	Ducker ,Ph.D. Dalia
Chinese Herb/Chemotherapy Interactions in Breast Cancer			2003 (Cycle IX)	$200,000
	University of California, San Francisco	Campbell ,Ph.D. Michael
Chinese Herbal Therapy (CHT) for Symptom Management			2000 (Cycle VI)	$200,000
	University of California, San Francisco	Rugo ,M.D. Hope
Chromatin Regulation of Breast Cancer Cell Senescence			1998 (Cycle IV)	$231,844
	Lawrence Berkeley National Laboratory	Kaufman ,Ph.D. Paul
Circuit Training to Lower Breast Cancer Risk in Latina Teens			2007 (Cycle 13)	$244,374
	University of Southern California	Davis ,Ph.D. Jaimie
Clinical Trials Education and Access for Underserved Women			2011 (Cycle 17)	$93,906
	SHANTI	Caprio ,Maria
Clinical Trials Education and Access for Underserved Women			2011 (Cycle 17)	$74,875
	University of California, San Francisco	Joseph ,Ph.D. Galen
Clinical Utility of Breast Cancer DNA Markers in Plasma			1999 (Cycle V)	$372,242
	John Wayne Cancer Institute	Hoon ,MSc, Ph.D. David
Clinical Utility of Breast Cancer DNA Markers in Serum			2001 (Cycle VII)	$470,520
	John Wayne Cancer Institute	Hoon ,MSc, Ph.D. David
Cloning of Senescence Genes in Mammary Epithelial Cells			1999 (Cycle V)	$75,034
	Stanford University	Zhang ,Ph.D. Hong
Cloning of the X Chromosome's Putative Tumor Suppressor Gene			2002 (Cycle VIII)	$284,375
	The Burnham Institute for Medical Research	Malkhosyan ,Ph.D. Sergei
Clotting Breast Cancer			2002 (Cycle VIII)	$98,986
	University of California, Irvine	Samoszuk ,M.D. Michael
Coactivators in Mammary Gland Development and Tumorigenesis			2001 (Cycle VII)	$86,400
	Salk Institute for Biological Studies	Wang ,Ph.D. Zhiyong
Cognitive Changes After Adjuvant Therapy for Breast Cancer			2000 (Cycle VI)	$199,997
	University of California, Los Angeles	Rausch ,M.S., Ph.D. Helen Rebecca
Combating Breast Cancer with the Wellderly Immune Repertoire			2011 (Cycle 17)	$473,750
	Scripps Research Institute	Felding-Habermann ,Ph.D. Brunhilde
Combating Breast Cancer with the Wellderly Immune Repertoire			2009 (Cycle 15)	$284,718
	Scripps Research Institute	Felding-Habermann ,Ph.D. Brunhilde
Combined Imaging Modalities for Breast Cancer			2006 (Cycle 12)	$148,772
	University of California, Irvine	Gulsen ,Ph.D. Gultekin
Combined Optical and MRI Imaging for Breast Cancer			2003 (Cycle IX)	$58,304
	University of California, Irvine	Merritt ,B.S. Sean
Common Genetic Variation & Breast Cancer: A Genomic Approach			2003 (Cycle IX)	$462,925
	University of Southern California	Haiman ,Sc.D. Christopher
Communicating Breast Cancer Risk in Ethnically Diverse Women			2000 (Cycle VI)	$244,199
	LA Biomedical Research Institute at Harbor-UCLA Medical Center	Lillington ,R.N., M.N., DNSc. Linda
Communication, Content & Impact of Genetics in Breast Cancer			1999 (Cycle V)	$630,150
	City of Hope National Medical Center	MacDonald ,R.N., M.S., APNG Deborah
Community Breast Cancer Screening & Prevention Conferences			2008 (Cycle 14)	$24,919
	Beckman Research Institute of the City of Hope	Weitzel ,M.D. Jeffrey
Competition for ADA2 and 3 to Inhibit p53 in Breast Cancer			2007 (Cycle 13)	$21,574
	University of California, Irvine	Yang ,M.D.,M.S. Min
Complement-mediated Stem Cell Recruitment to Breast Cancer			2010 (Cycle 16)	$136,500
	Torrey Pines Institute for Molecular Studies	Schraufstatter ,M.D. Ingrid
Compositional Breast Density as a Risk Factor			2002 (Cycle VIII)	$100,000
	University of California, San Francisco	Cummings ,B.A., M.D. Steven
Compositional Breast Density as a Risk Factor			2002 (Cycle VIII)	$100,000
	University of California, San Francisco	Kerlikowske ,M.S., M.D. Karla
Compositional Breast Density as a Risk Factor			2002 (Cycle VIII)	$100,000
	University of California, San Francisco	Shepherd ,Ph.D. John
Compounds Blocking Assembly of LRH-1 in Breast Cancer			2009 (Cycle 15)	$90,000
	University of California, San Francisco	Benod ,Ph.D. Cindy
Computer-Aided Diagnosis in Digital Mammography			1997 (Cycle III)	$214,200
	Charles R. Drew University of Medicine & Science	Sklansky ,Eng.Sc.D. Jack
Computer-Aided Discovery of Novel Breast Cancer Therapeutics			2000 (Cycle VI)	$112,041
	Molecular Research Institute	Dawson ,Ph.D. Marcia
Computer-Aided Discovery of Novel Breast Cancer Therapeutics			2000 (Cycle VI)	$112,041
	Molecular Research Institute	Harris ,Ph.D. Danni
Constructed Meaning and Stress in Breast Cancer Experience			2002 (Cycle VIII)	$61,536
	University of California, Los Angeles	Mitchell ,M.A. Jill
Consultation Support for Diverse Rural Breast Patients			2005 (Cycle 11)	$38,437
	University of California, San Francisco	Belkora ,Ph.D. Jeffrey
Consultation Support for Diverse Rural Breast Patients			2005 (Cycle 11)	$35,664
	Mendocino Cancer Resource Center	O'Donnell ,Sara
Consultation Support for Diverse Rural Breast Patients			2005 (Cycle 11)	$40,790
	Humboldt Community Breast Health Project	Elsbree ,MBA Dawn
Control of Aromatase Expression in Breast Cancer			2004 (Cycle 10)	$59,631
	Beckman Research Institute of the City of Hope	Kijima ,M.S. Ikuko
Control of BRCA2-mediated Homologous Recombination			2009 (Cycle 15)	$90,000
	University of California, Davis	Meyer ,Ph.D. Damon
Control of DNA Replication in Breast Cancer			1997 (Cycle III)	$47,543
	Stanford University	Wolf ,M.D. Dieter
Control of Estrogen Production in Breast Cancer			1995 (Cycle I)	$342,712
	Beckman Research Institute of the City of Hope	Chen ,Ph.D. Shiuan
Correlates of Lymphedema Severity and Access to Intervention			2003 (Cycle IX)	$107,396
	Women's Cancer Resource Center	Eversley ,Ph.D. Rani
Correlates of Lymphedema Severity and Access to Intervention			2003 (Cycle IX)	$107,396
	Women's Cancer Resource Center	Wardlaw ,Linda
Correlates of Lymphedema Severity and Access to Intervention			2003 (Cycle IX)	$107,396
	Women's Cancer Resource Center	Moorehead ,Dolores
Cost-effectiveness Analysis to Inform BC Screening Policy			2011 (Cycle 17)	$149,996
	University of California, Davis	Melnikow ,M.D., M.P.H. Joy
Cost-effectiveness of Breast MRI Screening by Cancer Risk			2005 (Cycle 11)	$49,647
	Stanford University	Kurian ,M.D. Allison
COX-2 and Apoptosis Regulation in Breast Cancer			1999 (Cycle V)	$75,596
	The Burnham Institute for Medical Research	Kim ,Ph.D. Youngsoo
Cripto-A Breast Cancer Marker?			1995 (Cycle I)	$75,600
	The Burnham Institute for Medical Research	Niemeyer ,Ph.D. Christina
Cryptic Peptides-Based Vaccines for Breast Tumor Treatment			2003 (Cycle IX)	$371,110
	Sidney Kimmel Cancer Center	Lustgarten ,Ph.D. Joseph
Cyclin E Affects Growth Arrest in Breast Cancer Cells			2002 (Cycle VIII)	$50,386
	University of California, Davis	Dhillon ,Navdeep
Cytoskeletal Regulation of Invading Breast Cells			2007 (Cycle 13)	$20,123
	University of California, San Francisco	Jacobson ,Ph.D. Catherine

D Top

Decision Support in Rural Underserved North Coast Counties			2004 (Cycle 10)	$37,500
	Mendocino Cancer Resource Center	O'Donnell ,Sara
Decision Support in Rural Underserved North Coast Counties			2004 (Cycle 10)	$37,500
	Humboldt Community Breast Health Project	Ohnemus ,M.D. Julie
Decision Support in Rural Underserved North Coast Counties			2004 (Cycle 10)	$40,000
	University of California, San Francisco	Belkora ,Ph.D. Jeffrey
Defining a Role for Endothelial Precursor Cells in Breast			2002 (Cycle VIII)	$199,174
	La Jolla Institute for Molecular Medicine	Chen ,Sc.D. Longchuan
Defining Mammary Cancer Origins in a Mouse Model of DCIS			2005 (Cycle 11)	$149,950
	University of California, Davis	Borowsky ,M.D. Alexander
Defining Mutagenesis Pathways in Breast Cancer Evolution			2005 (Cycle 11)	$67,520
	Scripps Research Institute	Lis ,Ph.D. Ewa
Demographic Questions for California BC Research			2009 (Cycle 15)	$430,988
	Cancer Prevention Institute of California	Gomez ,PhD Scarlett
Determinants of Breast Cancer Treatment in the Underserved			2001 (Cycle VII)	$910,038
	University of California, Los Angeles	Maly ,M.D., M.S.P.H. Rose
Determinants of Breast-Conserving Surgery and Survival			1995 (Cycle I)	$65,235
	Public Health Institute	Morris ,DVM, MPVM, Ph.D. Cyllene
Determinants of Response to Microtubule Stabilizing Drugs			2007 (Cycle 13)	$66,302
	Stanford University	Spicakova ,Ph.D. Tatana
Determination of Stromal Gene Expression in Breast Cancer			2007 (Cycle 13)	$136,217
	Palo Alto Institute for Research & Education	West ,M.D., Ph.D. Robert
Development of a Breast MRI Computer-Aided Diagnosis System			2008 (Cycle 14)	$76,000
	University of California, Irvine	Nie ,M.S. Ke
Development of EGFR-Based Imaging Agents for Breast Cancer			1998 (Cycle IV)	$69,580
	Lawrence Berkeley National Laboratory	VanBrocklin ,Ph.D. Henry
Dialogue with Breast Cancer Survivors			2006 (Cycle 12)	$23,995
	San Francisco State University	Yoo ,Ph.D. Grace
Diet & Breast Cancer in the California Teachers Study Cohort			1998 (Cycle IV)	$149,094
	Cancer Prevention Institute of California	Horn-Ross ,Ph.D. Pamela
Dietary Fat, Fat Metabolizing Genes and Breast Cancer Risk			2001 (Cycle VII)	$383,740
	University of Southern California	Ingles ,DrPH Sue Ann
Dietary Indole Analogs for Breast Cancer Prevention			1998 (Cycle IV)	$435,595
	SRI International	Jong ,Ph.D. Ling
Dietary Indole Analogs Inhibit Breast Cancer Cell Invasion			2003 (Cycle IX)	$381,491
	SRI International	Jong ,Ph.D. Ling
Dietary Indole Effect on Estrogen Urinary Metabolites			2001 (Cycle VII)	$89,925
	University of California, Berkeley	Firestone ,Ph.D. Gary
Dietary Indole Effect on Estrogen Urinary Metabolites			2001 (Cycle VII)	$89,925
	University of California, Berkeley	Bjeldanes ,Ph.D. Leonard
Dietary Indole Effect on Estrogen Urinary Metabolites			2001 (Cycle VII)	$89,925
	University of California, Berkeley	Dalessandri ,M.D.; F.A.C.S. Kathie
Dietary Indole Inhibition of Breast Cancer			1997 (Cycle III)	$150,000
	University of California, Berkeley	Firestone ,Ph.D. Gary
Dietary Metabolite Inhibition of Breast Cancer Cell Survival			2008 (Cycle 14)	$72,508
	University of California, Berkeley	Nicastro ,Ph.D. Holly
Differential Optical Mammography			2004 (Cycle 10)	$733,901
	SRI International	Faris ,Ph.D. Gregory
Differential Optical Mammography			2004 (Cycle 10)	$733,901
	SRI International	Comstock ,M.D. Christopher
Diffusion-Weighted MRI in Monitoring Breast Cancer Treatment			2009 (Cycle 15)	$48,115
	University of California, San Francisco	Singer ,B.S. Lisa
DigiMAM:A Sensitive Early Detection System for Breast Cancer			1996 (Cycle II)	$126,280
	Nova R & D, Inc.	Tumer ,Ph.D. Tumay
Digital Imaging for Hospital and Community Based Mammography			1995 (Cycle I)	$221,716
	University of California, Los Angeles	Valentino ,Ph.D. Daniel
Discovering Novel Cell-ECM Interactions in Breast Cells			2004 (Cycle 10)	$159,939
	California Pacific Medical Center Research Institute	Muschler ,Ph.D. John
Discovery and Study of Breast Cancer Secreted Proteins			2000 (Cycle VI)	$85,968
	Cedars-Sinai Medical Center	Williamson ,Ph.D. Elizabeth
Discovery of Fusion Genes in Breast Cancer			2009 (Cycle 15)	$160,000
	Stanford University	Pollack ,M.D., Ph.D. Jonathan
Disruption of Cyclin E/Cell Cycle In Breast Cancer Cells			1997 (Cycle III)	$75,600
	Scripps Research Institute	Sato ,Ph.D. Kevin
Dissecting the Role of Twist in Breast Cancer Metastasis			2008 (Cycle 14)	$76,000
	University of California, San Diego	Low-Marchelli ,B.S. Janine
Dissection of Signaling Events in the Mammary Gland in Vivo			2003 (Cycle IX)	$86,400
	The Burnham Institute for Medical Research	Ke ,Ph.D. Yuehai
DNA Packaging Defects in Breast Cancer			2000 (Cycle VI)	$333,261
	Lawrence Berkeley National Laboratory	Kohwi-Shigematsu ,Ph.D. Terumi
DNA Polymorphisms and Breast Cancer in a Multi-ethnic Cohort			2000 (Cycle VI)	$80,949
	University of Southern California	Henderson ,M.D. Brian
Do Community Cancer Groups Enhance Well-being?			1999 (Cycle V)	$74,968
	Stanford University	Cordova ,Ph.D. Matthew
Do Community Cancer Groups Reduce Stress?			1998 (Cycle IV)	$0
	Molecular Medicine Research Institute	Kronenwetter ,Ph.D. Carol
Do Community Cancer Support Groups Reduce Physiologic Stress			1998 (Cycle IV)	$726,152
	Stanford University	Spiegel ,M.D. David
Do Community Cancer Support Groups Reduce Physiological Stre			1998 (Cycle IV)	$0
	The Wellness Community-National	Golant ,Ph.D. Mitch
Does a Peer Navigator Improve Quality of Life at Diagnosis?			2000 (Cycle VI)	$159,147
	Stanford University	Spiegel ,M.D. David
Does a Peer Navigator Improve Quality of Life at Diagnosis?			2000 (Cycle VI)	$159,147
	Stanford University	Bliss-Isberg ,Ph.D. Caroline
Does a Peer Navigator Improve Quality of Life at Diagnosis?			2001 (Cycle VII)	$772,073
	Stanford University	Spiegel ,M.D. David
Does a Peer Navigator Improve Quality of Life at Diagnosis?			2001 (Cycle VII)	$772,073
	Stanford University	Bliss-Isberg ,Ph.D. Caroline
Does Cell Aging Cause Breast Cancer?			1997 (Cycle III)	$239,303
	Lawrence Berkeley National Laboratory	Campisi ,Ph.D. Judith
Does Change in Emotional Expression Mediate Cancer Survival?			1995 (Cycle I)	$74,848
	Stanford University	Giese-Davis ,Ph.D. Janine
Does Disregulaton of Centrosomes Cause Breast Cancer?			2003 (Cycle IX)	$80,000
	University of California, San Francisco	McDermott ,Ph.D. Kimberly
Does Mobile Mammography Increase Screening in Older Women?			1998 (Cycle IV)	$0
	University of California, Los Angeles	Bastani ,Ph.D. Roshan
Does Mobile Mammography Increase Screening in Older Women?			1998 (Cycle IV)	$520,640
	University of California, Los Angeles	Reuben ,M.D. David
Does Mobile Mammography Increase Screening in Older Women?			1998 (Cycle IV)	$520,640
	University of California, Los Angeles	Bastani ,Ph.D. Roshan
Does the BLM Gene Co-regulate BRCA1 in DNA Damage Response?			2002 (Cycle VIII)	$80,671
	Lawrence Berkeley National Laboratory	Davalos ,Ph.D. Albert
Drug Dose Tailoring Based on Patient-Specific Factors			2002 (Cycle VIII)	$11,827
	University of California, San Francisco	Case Lo ,Ph.D.c Christine

E Top

Early Breast Cancer Detection Using 3D Ultrasound Tomography			2005 (Cycle 11)	$149,879
	University of California, San Diego	Nelson ,Ph.D. Thomas
Early Breast Cancer Detection Using 3D Ultrasound Tomography			2007 (Cycle 13)	$225,000
	University of California, San Diego	Nelson ,Ph.D. Thomas
Early Breast Cancer Detection with Fiberoptic-CMOS Detector			1996 (Cycle II)	$171,879
	University of California, Davis	Seibert ,Ph.D. J. Anthony
Early Detection of Breast Cancer and it Recurrence			2001 (Cycle VII)	$365,446
	Huntington Medical Research Institute	Imam ,M.S., Ph.D. Syed Ashraf
Early detection of breast cancer and its recurrence			1996 (Cycle II)	$271,619
	University of Southern California	Imam ,M.S., Ph.D. Syed Ashraf
Early Transitions in Breast Cancer			2003 (Cycle IX)	$199,424
	University of California, San Francisco	Tlsty ,Ph.D. Thea
ECM-Regulated Transcription in Breast Cancer			1997 (Cycle III)	$62,776
	Lawrence Berkeley National Laboratory	Pujuguet ,Ph.D. Philippe
Effect of Breast Cell Environment on Repair of DNA Damage			2002 (Cycle VIII)	$80,656
	Lawrence Berkeley National Laboratory	Rizki ,Ph.D. Aylin
Effect of Bright Light on Fatigue in Breast Cancer			2005 (Cycle 11)	$141,282
	University of California, San Diego	Ancoli-Israel ,Ph.D. Sonia
Effectiveness of Electronic Support Groups for Breast Cancer			1999 (Cycle V)	$98,605
	University of California, San Francisco	Lieberman ,Ph.D. Morton
Effectiveness of Internet vs. Face to Face Support Groups			2001 (Cycle VII)	$251,763
	University of California, San Francisco	Lieberman ,Ph.D. Morton
Effectiveness of Internet vs. Face to Face Support Groups			2001 (Cycle VII)	$316,851
	The Wellness Community-National	Golant ,Ph.D. Mitch
Effects of Stress and Support on Delay in Cancer Treatment			1995 (Cycle I)	$76,087
	Stanford University	Angell ,Ph.D. Karyn
Efficacy of a Community Program in Increasing Access to STAR			2001 (Cycle VII)	$35,211
	Association of Black Women Physicians	Brown ,M.D. Kathleen
Efficacy of a Community Program in Increasing Access to STAR			2001 (Cycle VII)	$68,350
	University of California, Los Angeles	Ganz ,M.D. Patricia
EGFR Structure for Drug Design Targeted to Breast Cancer			1995 (Cycle I)	$68,730
	University of California, San Diego	Chan ,Ph.D. Chung-leung
Electronics for High Resolution Breast-Dedicated PET			2010 (Cycle 16)	$76,000
	Stanford University	Lau ,M.S. Frances
Empowering Acupuncturists to Cooperate with Oncologists			2004 (Cycle 10)	$89,391
	University of California, Los Angeles	Johnston ,Ph.D. Michael
Engineered antibodies for imaging & therapy of breast cancer			1996 (Cycle II)	$87,924
	Beckman Research Institute of the City of Hope	Wu ,Ph.D. Anna
Engineering Antibodies Specific for Breast Cancer Proteases			2001 (Cycle VII)	$20,193
	University of California, San Francisco	Sun ,Ph.D. Jeonghoon
Engineering EGFR Antagonists for Breast Tumor Targeting			2007 (Cycle 13)	$75,992
	Stanford University	Lahti ,M.S. Jennifer
Enhanced HER-2 Directed Liposomal Therapeutics			2001 (Cycle VII)	$131,823
	Hermes Biosciences, Inc.	Drummond ,Ph.D. Daryl
Enhanced HER-2 Directed Liposomal Therapeutics			2001 (Cycle VII)	$332,938
	California Pacific Medical Center Research Institute	Drummond ,Ph.D. Daryl
Enhanced lysosomal degradation of growth factor receptors			1996 (Cycle II)	$295,246
	University of California, San Diego	Gill ,M.D. Gordon
Enhancing breast cancer sensitivity to chemotherapy			1997 (Cycle III)	$380,825
	Sidney Kimmel Cancer Center	Mercola ,M.D., Ph.D. Daniel
Enhancing Trastuzumab Therapy with an NK Activating Antibody			2010 (Cycle 16)	$224,749
	Stanford University	Levy ,M.D. Ronald
Environmental Causes of Breast Cancer Across Generations			2009 (Cycle 15)	$5,000,000
	Public Health Institute	Cohn ,Ph.D., MPH, MCP Barbara
Epidemiology of Physical Activity and Ovarian Function			1998 (Cycle IV)	$0
	Kaiser Foundation Research Institute	Sternfeld ,Ph.D. Barbara
Epigenetic changes as modifiers of BRCA1/ BRCA2 cancer risk			2011 (Cycle 17)	$251,128
	Beckman Research Institute of the City of Hope	Neuhausen ,Ph.D. Susan
Epithelial Polarity, Organization and the Angiogenic Switch			2004 (Cycle 10)	$75,000
	University of California, San Francisco	Boudreau ,Ph.D. Nancy
Epstein-Barr Virus in Breast Cancer Tissues			2003 (Cycle IX)	$275,260
	Cancer Prevention Institute of California	Glaser ,Ph.D. Sally
ErbB2 and Control of Growth in Breast Cancer Cells			1995 (Cycle I)	$144,936
	University of California, San Diego	Cadena ,Ph.D. Deborah
Estrogen Formation and Breast Cancer Risk			1997 (Cycle III)	$244,889
	University of Southern California	Coetzee ,Ph.D. Gerhard
Estrogen metabolizing genes, soy and breast cancer in Asians			1999 (Cycle V)	$1,664,130
	University of Southern California	Wu ,Ph.D. Anna
Estrogen Receptor Beta Agonists to Prevent Breast Cancer			2005 (Cycle 11)	$150,000
	University of California, San Francisco	Kushner ,Ph.D. Peter
Estrogen Receptor Regulation in Breast Cancer			1995 (Cycle I)	$75,238
	Stanford University	McPherson ,Ph.D. Lisa
Estrogen receptor-interacting proteins in breast cancer			1996 (Cycle II)	$492,719
	University of Southern California	Stallcup ,Ph.D. Michael
Evaluating the Role of the RIN1 Gene in Breast Cancer			2005 (Cycle 11)	$71,835
	University of California, Los Angeles	Milstein ,B.S. Marc
Evaluation of Essiac Tea to Prevent Mammary Tumors			2001 (Cycle VII)	$182,593
	Lawrence Livermore National Laboratory	Kulp ,Ph.D. Kristen
Exercise and Risk of Breast Cancer Recurrence			1998 (Cycle IV)	$236,299
	University of Southern California	Pike ,Ph.D. Malcolm
Exercise and the Prevention of Breast Cancer			1995 (Cycle I)	$367,464
	University of Southern California	Shames ,Ph.D., M.P.H. Lisa
Exercise, Hormones and Breast Cancer Prevention			1999 (Cycle V)	$142,451
	University of Southern California	Williams-Hill ,Ph.D. Donna
Expanding Rural Access: Distance Delivery of Support Groups			2007 (Cycle 13)	$197,282
	The Sierra Fund	Kreshka ,M.A. Mary Anne
Expanding Rural Access: Distance Delivery of Support Groups			2007 (Cycle 13)	$197,282
	The Sierra Fund	Ferrier ,R.N. Susan
Expanding Rural Access: Distance Delivery of Support Groups			2007 (Cycle 13)	$228,567
	Northern Sierra Rural Health Network	Kreshka ,M.A. Mary Anne
Expanding Rural Access: Distance Delivery of Support Groups			2007 (Cycle 13)	$228,567
	Northern Sierra Rural Health Network	Ferrier ,R.N. Susan
Expanding Rural Access: Distance Delivery of Support Groups			2007 (Cycle 13)	$290,337
	Stanford University	Koopman ,Ph.D. Cheryl
Expanding Rural Access: Distance Delivery of Support Groups			2004 (Cycle 10)	$62,656
	Stanford University	Koopman ,Ph.D. Cheryl
Expanding Rural Access: Distance Delivery of Support Groups			2004 (Cycle 10)	$75,306
	Northern Sierra Rural Health Network	Kreshka ,M.A. Mary Anne
Expanding Rural Access: Distance Delivery of Support Groups			2004 (Cycle 10)	$75,306
	Northern Sierra Rural Health Network	Ferrier ,R.N. Susan
Exploring Disparities,Environmental Risk Factors in Teachers			2009 (Cycle 15)	$130,837
	Cancer Prevention Institute of California	Reynolds ,Ph.D. Peggy
Exploring Disparities,Environmental Risk Factors in Teachers			2009 (Cycle 15)	$130,837
	Cancer Prevention Institute of California	Hurley ,MPH Susan
Exploring the Role of PARP Inhibitors in Breast Cancer			2007 (Cycle 13)	$157,516
	Stanford University	Cimprich ,Ph.D. Karlene

F Top

Factors Influencing Breast Cancer Screening Among Older Thai			2006 (Cycle 12)	$88,427
	Thai Health and Information Service	Natipagon-Shah ,Ph.D., R.N. Bulaporn
Factors Influencing Breast Cancer Screening Among Older Thai			2006 (Cycle 12)	$85,430
	University of San Diego	Clark ,PhD, RN Mary Jo
False-Positive Mammograms: A Barrier to Annual Screening?			1995 (Cycle I)	$117,783
	Cancer Prevention Institute of California	Gardiner ,DrPH Phillip
Fate Mapping of Progesterone Receptor Positive Breast Cells			1997 (Cycle III)	$243,380
	Lawrence Berkeley National Laboratory	Harris ,Ph.D. G. Shyamala
Fatty Acid Synthase and Breast Cancer			2002 (Cycle VIII)	$86,400
	The Burnham Institute for Medical Research	Knowles ,Ph.D. Lynn
FGFR2 Signaling in Human Breast Cancer Cells			2008 (Cycle 14)	$100,000
	University of California, San Diego	Donoghue ,Ph.D. Daniel
Fiber, Estrogen and Breast Cancer in Mexican American Women			2002 (Cycle VIII)	$159,117
	University of Southern California	Pike ,Ph.D. Malcolm
Filipina Breast Cancer Support: What Model is Meaningful?			2006 (Cycle 12)	$10,000
	University of California, San Francisco	Jocson ,BA Edwin
Filipina Breast Cancer Support: What Model is Meaningful?			2006 (Cycle 12)	$10,000
	University of California, San Francisco	Burke ,Ph.D. Nancy
Finding BRCA1 Ubiquitinated Substrates in Breast Cancer			2009 (Cycle 15)	$191,000
	The Burnham Institute for Medical Research	Spruck ,Ph.D. Charles
FKBP Proteins as Molecular Targets in Breast Cancer Therapy			2004 (Cycle 10)	$88,906
	California Pacific Medical Center Research Institute	Fong ,Ph.D. Sylvia
Folate, DNA Methylation, and Breast Cancer Metastasis			2008 (Cycle 14)	$78,647
	University of California, Davis	Marple ,Ph.D. Teresa
Fresno Breast Cancer Navigator Pilot Program			2006 (Cycle 12)	$50,400
	California State University, Fresno Foundation	Capitman ,Ph.D. John
Fresno Breast Cancer Navigator Pilot Program			2006 (Cycle 12)	$138,500
	San Joaquin Valley Health Consortium	Wallace ,Mary
Fresno Breast Cancer Navigator Pilot Program			2006 (Cycle 12)	$138,500
	San Joaquin Valley Health Consortium	Zweifler ,M.D. John
Functional Analysis of BORIS, A Novel DNA-binding Protein			2003 (Cycle IX)	$92,426
	Lawrence Berkeley National Laboratory	Yaswen ,Ph.D. Paul
Functional Breast MRI with BOLD Contrast			2008 (Cycle 14)	$75,994
	Stanford University	Rakow-Penner ,M.S. Rebecca

G Top

Galectin-4 As a New Marker for Breast Cancer			1997 (Cycle III)	$196,900
	La Jolla Institute for Allergy and Immunology	Huflejt ,Ph.D. Margaret
GATA-3 Expression in Hormone Responsive Breast Cancer			1999 (Cycle V)	$232,444
	Stanford University	Weigel ,M.D., Ph.D. Ronald
Gene Expression Profiling in the Developing Mammary Gland			2004 (Cycle 10)	$60,000
	University of California, San Francisco	Kouros-Mehr ,B.S. Hosein
Gene Therapy for Breast Cancer			1997 (Cycle III)	$293,383
	California Pacific Medical Center Research Institute	Debs ,M.D. Robert
Gene-Diet/Tobacco Interactions in Breast Cancer in Asians			1997 (Cycle III)	$745,223
	University of Southern California	Wu ,Ph.D. Anna
Generativity and Meaning-making as Resilience Factors in Br			1999 (Cycle V)	$0
	Stanford University	Azarow ,Ph.D. Jay
Genes Determining Estrogen Susceptibility in Breast Cancer			2000 (Cycle VI)	$86,400
	Stanford University	Wei ,Ph.D. Wensheng
Genes in Hormone Metabolism Pathway and Breast Cancer			2008 (Cycle 14)	$134,996
	University of Southern California	Lee ,Eunjung
Genes Involved in Immortalization of Human Mammary Cells			1998 (Cycle IV)	$251,476
	Lawrence Berkeley National Laboratory	Stampfer ,Ph.D. Martha
Genes That Modulate Dioxin-Induced Breast Cancer			2001 (Cycle VII)	$84,731
	Stanford University	Lu ,Ph.D. Quan
Genes Which Cause Increased Cellular DNA in Breast Cancer			1995 (Cycle I)	$493,585
	University of Southern California	Press ,M.D., Ph.D. Michael
Genetic Alterations in MRI Screen-Detected Breast Lesions			2002 (Cycle VIII)	$145,649
	Stanford University	Ford ,M.D. James
Genetic Alterations in MRI Screen-Detected Breast Lesions			2002 (Cycle VIII)	$145,649
	Stanford University	Plevritis ,Ph.D. Sylvia
Genetic Analysis of ErbB Signaling in C. Elegans			2001 (Cycle VII)	$85,633
	California Institute of Technology	Moghal ,Ph.D. Nadeem
Genetic and Environmental Modifiers of Breast Cancer Risk			2000 (Cycle VI)	$287,979
	University of California, Irvine	Ziogas ,Ph.D. Argyrios
Genetic Aspects of Physiological Response During Lactation			2001 (Cycle VII)	$593,000
	University of California, San Diego	Johnson ,Ph.D. Randall
Genetic Changes in Normal Epithelium of the Cancerous Breast			2000 (Cycle VI)	$616,342
	California Pacific Medical Center Research Institute	Dairkee ,Ph.D. Shanaz
Genetic Repair of Oxidative Damage: Effect of Estrogen			1997 (Cycle III)	$606,017
	The Burnham Institute for Medical Research	Rampino ,Ph.D. Nicholas
Genetic Susceptibility to Breast Cancer			1996 (Cycle II)	$75,436
	University of Southern California	Feigelson ,Ph.D., M.P.H. Heather
Genetic Susceptibility to Breast Cancer			1995 (Cycle I)	$79,669
	University of Southern California	Henderson ,M.D. Brian
Genetics of Tamoxifen Response			2008 (Cycle 14)	$803,111
	University of California, San Francisco	Ziv ,M.D. Elad
Genetics, Obesity, and Breast Cancer Risk			2003 (Cycle IX)	$517,422
	University of California, Los Angeles	Carpenter ,M.P.H., Ph.D. Catherine
Geographic Variation in Breast Cancer Stage at Diagnosis			2001 (Cycle VII)	$425,497
	University of California, Los Angeles	Davidson ,Ph.D. Pamela
Global Analysis of Protein Ubiquitination in Breast Cancer			2008 (Cycle 14)	$89,558
	The Burnham Institute for Medical Research	Grotegut ,Ph.D. Stefan
Global Analysis of Protein Ubiquitination in Breast Cancer			2008 (Cycle 14)	$45,000
	Sidney Kimmel Cancer Center	Grotegut ,Ph.D. Stefan
Global Gene Regulation by SATB1 in Metastatic Breast Cancer			2002 (Cycle VIII)	$161,176
	Lawrence Berkeley National Laboratory	Kohwi-Shigematsu ,Ph.D. Terumi
Glycoconjugates: Novel Non-toxic Therapies for Breast Cancer			2003 (Cycle IX)	$191,278
	Sidney Kimmel Cancer Center	Huflejt ,Ph.D. Margaret
Grape Seed as a Natural Breast Cancer Chemopreventive Agent			2005 (Cycle 11)	$251,381
	Beckman Research Institute of the City of Hope	Palomares ,M.D., M.S. Melanie Ruth
Grape Seed as Aromatase Inhibitor for Breast Cancer Risk			2004 (Cycle 10)	$0
	Beckman Research Institute of the City of Hope	Chen ,Ph.D. Shiuan
Grape Seed as Aromatase Inhibitor for Breast Cancer Risk			2004 (Cycle 10)	$0
	Beckman Research Institute of the City of Hope	Palomares ,M.D., M.S. Melanie Ruth
Grapefruit, Hormones, and Postmenopausal Breast Cancer Risk			2008 (Cycle 14)	$243,717
	University of Southern California	Monroe ,Ph.D. Kristine
Group Intervention for Women at High Risk for Breast Cancer			1995 (Cycle I)	$42,836
	University of California, Los Angeles	Wellisch ,Ph.D. David
Growth Factor Control of Breast Tumor Cell Proliferation			1995 (Cycle I)	$35,000
	University of California, San Diego	Kurten ,Ph.D. Richard
Growth Factor Receptor Activation in Breast Cancer			1997 (Cycle III)	$267,291
	Scripps Research Institute	Maruyama ,Ph.D. Ichiro
Growth Inhibition of Breast Cancer Cells by Interferons			1995 (Cycle I)	$225,000
	University of California, Los Angeles	Shuai ,Ph.D. Ke

H Top

Harnessing Technology to Improve Mammography Effectiveness			1996 (Cycle II)	$370,070
	University of California, San Francisco	Esserman ,M.D. Laura
Health Anxiety as a Risk for Insomnia in Breast Cancer			2009 (Cycle 15)	$73,455
	University of California, San Diego	Rissling ,M.S. Michelle
Health Literacy in Older Patient's Breast Cancer Treatment			2009 (Cycle 15)	$180,890
	University of California, Los Angeles	Naeim ,M.D., Ph.D. Arash
Hec1 Inhibitor Synergizes With Taxol in Breast Cancer			2010 (Cycle 16)	$0
	University of California, Irvine	Goldblatt ,Ph.D. Erin
HER2 Co-Amplified Genes and Treatment Response			2010 (Cycle 16)	$243,000
	University of Southern California	Press ,M.D., Ph.D. Michael
HER2/Neu DNA Vaccines for Breast Cancer			1999 (Cycle V)	$197,249
	University of California, San Francisco	Campbell ,Ph.D. Michael
HER-2/neu Gene Variations and Breast Cancer Risk			2001 (Cycle VII)	$1,182,463
	University of Southern California	Press ,M.D., Ph.D. Michael
Her-2/neu-Crosreactive Analogs as Targets for Breast Cancer			2004 (Cycle 10)	$371,110
	Sidney Kimmel Cancer Center	Lustgarten ,Ph.D. Joseph
HER3 Infidelity and Resistance to Tyrosine Kinase Inhibitors			2005 (Cycle 11)	$150,000
	University of California, San Francisco	Moasser ,M.D. Mark
Herba Scutellaria Barbatae for Metastatic Breast Cancer			2001 (Cycle VII)	$232,364
	University of California, San Francisco	Rugo ,M.D. Hope
Hereditary Breast Cancer and Novel Hispanic BRCA Mutations			2006 (Cycle 12)	$253,500
	Beckman Research Institute of the City of Hope	Weitzel ,M.D. Jeffrey
Heregulin-specific Diphtheria Toxin as a Cancer Therapy			1998 (Cycle IV)	$322,293
	Salk Institute for Biological Studies	Louie ,Ph.D. Gordon
High Resolution Breast Gamma Emission Imaging System			1996 (Cycle II)	$309,228
	University of Southern California	Singh ,Ph.D. Manbir
Histone Methylation as a Marker of Breast Cancer Progression			2005 (Cycle 11)	$162,500
	University of Southern California	Rice ,Ph.D. Judd
Homeobox Genes: A New Class of Human Breast Oncogenes?			1996 (Cycle II)	$70,000
	University of California, Santa Cruz	Lewis ,Ph.D. Michael
Hormonal Control of HER2neu and BRCA1 in Breast Cancer			1997 (Cycle III)	$286,676
	Sidney Kimmel Cancer Center	Reynolds ,Ph.D. Wanda
Hormonal Control of Normal Breast Tissue			1997 (Cycle III)	$0
	Cancer Research Institute of Contra Costa	Yang ,M.D., Ph.D. Jason
Hormonal Regulation of TGF Beta During Mammary Development			1998 (Cycle IV)	$758,817
	Lawrence Berkeley National Laboratory	Barcellos-Hoff ,Ph.D. Mary Helen
Hormone Receptors and Breast Cancer Survival			1997 (Cycle III)	$5,862
	University of Southern California	Enger ,Ph.D. Shelley
Hormone, Psychologic & Immunologic Factors & BC Survivorship			2004 (Cycle 10)	$286,036
	University of California, San Diego	Klonoff-Cohen ,Ph.D. Hillary
How are Collagenses Involved in Breast Cancer Metastasis?			1996 (Cycle II)	$584,513
	La Jolla Institute for Molecular Medicine	Strongin ,Ph.D. Alex
How Does Endostatin Inhibit Breast Cancer Angiogenesis?			1999 (Cycle V)	$292,535
	The Burnham Institute for Medical Research	Vuori ,M.D., Ph.D. Kristiina
How Indole-3 Carbinol Inhibits Breast Cancer Cell Growth			1999 (Cycle V)	$35,000
	University of California, Berkeley	Zhang ,Ph.D. Liqun JoAnn
How Women Decide to Seek Evaluation of Breast Symptoms			1995 (Cycle I)	$223,588
	University of California, San Francisco	Facione ,Ph.D., R.N., F.N.P. Noreen
Hox Genes in Normal Breast Development and Breast Cancer			1999 (Cycle V)	$40,393
	Lawrence Berkeley National Laboratory	Hagios ,Ph.D. Carmen
HOX Transcriptional Regulation of Angiogenesis			2002 (Cycle VIII)	$39,029
	University of California, San Francisco	Charboneau ,Ph.D. Aubri
Hox Transcriptional Regulation of Breast Tumor Angiogenesis			2004 (Cycle 10)	$30,890
	University of California, San Francisco	East ,Ph.D. Lucy
HSP27 Regulation of Breast Tumor Blood Vessel Growth			1995 (Cycle I)	$75,570
	Scripps Research Institute	Piotrowicz ,Ph.D. Randolph
Hybrid Grid-Detector to Improve Early Detection Imaging			1995 (Cycle I)	$263,310
	University of California, Davis	Boone ,Ph.D. John

I Top

Id-1 Expression During Breast Cancer Progression			1999 (Cycle V)	$78,031
	California Pacific Medical Center Research Institute	Desprez ,Ph.D. Pierre-Yves
ID4: a Prognostic Factor of Breast Cancer Metastasis			2005 (Cycle 11)	$283,200
	John Wayne Cancer Institute	Hoon ,MSc, Ph.D. David
Identification and Prognostic Value of ERb in Breast Cancer			2002 (Cycle VIII)	$150,000
	University of California, San Francisco	Leitman ,M.D., Ph.D. Dale
Identification of BRCA1 Ubiquitylation Targets			2003 (Cycle IX)	$75,000
	University of California, Irvine	Kaiser ,Ph.D. Peter
Identification of BRCA1 Ubiquitylation Targets			2005 (Cycle 11)	$199,600
	University of California, Irvine	Kaiser ,Ph.D. Peter
Identification of Metastasis Competent Breast Cancer Cells			2006 (Cycle 12)	$267,567
	La Jolla Institute for Molecular Medicine	Mueller ,Ph.D. Barbara
Identification of Metastasis Competent Breast Cancer Cells			2006 (Cycle 12)	$59,805
	Sidney Kimmel Cancer Center	Mueller ,Ph.D. Barbara
Identification of new candidate breast cancer genes			1996 (Cycle II)	$186,755
	University of California, San Francisco	Albertson ,Ph.D. Donna
Identification of new candidate breast cancer genes			1996 (Cycle II)	$135,748
	Lawrence Berkeley National Laboratory	Albertson ,Ph.D. Donna
Identification of Novel Id-1 Regulated Genes in Breast Cells			1999 (Cycle V)	$75,600
	California Pacific Medical Center Research Institute	Singh ,Ph.D. Jarnail
Identification of Novel Secreted Proteins of Breast Cancer			1999 (Cycle V)	$75,750
	Cedars-Sinai Medical Center	Koeffler ,M.D. Phillip
Identification of Pregnancy-associated Breast Cancer Genes			1997 (Cycle III)	$50,000
	University of California, Berkeley	Nandi ,Ph.D. Satyabrata
Identifying Accessible Targets in Human Breast Tumors			2002 (Cycle VIII)	$480,843
	Sidney Kimmel Cancer Center	Schnitzer ,M.D. Jan
Identifying Breast Cancer Targets for Protease Inhibitors			2000 (Cycle VI)	$42,120
	Scripps Research Institute	Liu ,Ph.D. Yongsheng
Identifying Metastatic Breast Cells from Peripheral Blood			2004 (Cycle 10)	$203,223
	Lawrence Livermore National Laboratory	Kulp ,Ph.D. Kristen
Identifying Metastatic Breast Cells from Peripheral Blood			2005 (Cycle 11)	$490,774
	Lawrence Livermore National Laboratory	Kulp ,Ph.D. Kristen
Identifying Novel Breast Cancer Tumor Suppressor Genes			1997 (Cycle III)	$97,500
	The Burnham Institute for Medical Research	Perucho ,Ph.D. Manuel
Identifying Novel Drugable Targets Against TNBC			2011 (Cycle 17)	$150,000
	University of California, San Francisco	Goga ,M.D., Ph.D. Andrei
Identifying Sources of Genomic Instability in Breast Cancer			2002 (Cycle VIII)	$119,059
	Stanford University	Cimprich ,Ph.D. Karlene
Identifying the Breast Cancer Target for Indole-3-Carbinol			2000 (Cycle VI)	$40,000
	University of California, Berkeley	Chatterji ,Ph.D. Urmi
IGF System and Breast Cancer in Postmenopausal Women			1999 (Cycle V)	$122,041
	University of Southern California	Henderson ,M.D. Brian
IGF-II and cathespin D in tumor growth and metastasis			1996 (Cycle II)	$353,776
	Loma Linda University	De Leon ,Ph.D. Daisy
Imaging of Novel Stem Cell Therapy Targeting Breast Cancer			2008 (Cycle 14)	$239,213
	Stanford University	Wu ,M.D., Ph.D. Joseph
Imaging RhoC-induced Breast Cancer Invasion and Angiogenesis			2005 (Cycle 11)	$15,725
	Scripps Research Institute	Stoletov ,Ph.D. Konstantin
Imaging RhoC-induced Breast Cancer Invasion and Angiogenesis			2005 (Cycle 11)	$119,220
	University of California, San Diego	Stoletov ,Ph.D. Konstantin
Immigrant Experience & Breast Cancer Risk in Asians			2011 (Cycle 17)	$730,192
	Cancer Prevention Institute of California	Gomez ,PhD Scarlett
Immortalization of Human Mammary Epithelial Cells by ZNF217			2000 (Cycle VI)	$249,255
	Lawrence Berkeley National Laboratory	Yaswen ,Ph.D. Paul
Immune responses to breast cancers: function of TRAF protein			1996 (Cycle II)	$284,581
	The Burnham Institute for Medical Research	Reed ,M.D., Ph.D. John
Immune-Function Genes and Race Differences in Breast Cancer			2002 (Cycle VIII)	$209,688
	Cancer Prevention Institute of California	Glaser ,Ph.D. Sally
Impact of Breast Cancer and its Therapy on Bone Density			2002 (Cycle VIII)	$300,000
	University of California, Los Angeles	Crandall ,M.D. Carolyn
Impact of Opioid Peptides on Breast Cancer Etiology			1999 (Cycle V)	$0
	Lawrence Livermore National Laboratory	Turteltaub ,Ph.D. Kenneth
Impact of Physician Attitudes on Mammography Screening Rates			1995 (Cycle I)	$13,746
	University of California, San Francisco	Komaromy ,M.D. Miriam
Improved delivery of pharmaceuticals to breast cancer			1996 (Cycle II)	$145,492
	University of California, San Francisco	Papahadjopoulos ,Ph.D. Demetrios
Improved Delivery of Pharmaceuticals to Breast Cancer			1996 (Cycle II)	$60,597
	California Pacific Medical Center Research Institute	Kirpotin ,Ph.D. Dmitri
Improving Access to Mammography in an Urban Underserved Area			1996 (Cycle II)	$520,005
	Charles R. Drew University of Medicine & Science	Allen ,DrPH Bruce
In Vivo Effects of Chinese Herbal Extracts on Breast Cancer			2001 (Cycle VII)	$199,600
	University of California, San Francisco	Campbell ,Ph.D. Michael
In Vivo MRS for Cancer Diagnosis and Treatment Monitoring			2006 (Cycle 12)	$90,000
	University of California, Irvine	Baek ,Ph.D. Hyeon-Man
Increasing Annual Recall in State Early Detection Programs			1997 (Cycle III)	$58,530
	CHG Foundation	Howard ,Nicole
Increasing Breast Health Access for Women With Disabilities			1998 (Cycle IV)	$502,616
	Alta Bates Summit Medical Foundation	D'Onofrio ,DrPH Carol
Increasing Breast Health Access for Women With Disabilities			1998 (Cycle IV)	$502,616
	Alta Bates Summit Medical Foundation	Cupolo Freeman ,Ann
Increasing Mammography Among Latinas with Disabilities			2006 (Cycle 12)	$50,000
	University of California, San Francisco	Kaye ,Ph.D. H. Stephen
Increasing Mammography Among Latinas with Disabilities			2006 (Cycle 12)	$125,000
	Central Coast Center for Independent Living	Quezada ,Elsa
Increasing Mammography Screening Among Native Women			2010 (Cycle 16)	$591,281
	University of California, Davis	von Friederichs-Fitzwater,Ph.D. Marlene
Increasing Mammography Screening Among Native Women			2010 (Cycle 16)	$591,281
	University of California, Davis	Navarro ,Linda
Increasing Mammography Screening in Latinas with Diabetes			2008 (Cycle 14)	$493,666
	Golden Valley Health Centers	Noguera ,M.S. Christine
Increasing Mammography Screening in Latinas with Diabetes			2008 (Cycle 14)	$252,803
	San Diego State University Research Foundation	Roussos ,PhD, MPH Stergios
Increasing the Voice of African Americans in Research			2008 (Cycle 14)	$25,000
	Beckman Research Institute of the City of Hope	Ashing-Giwa ,Ph.D. Kimlin
Indole (I3C) Control of Breast Cancer by ER Downregulation			2007 (Cycle 13)	$76,000
	University of California, Berkeley	Marconett ,B.S. Crystal
Indole Derivatives as Novel Breast Cancer Therapeutics			1999 (Cycle V)	$150,000
	University of California, Berkeley	Firestone ,Ph.D. Gary
Infinite Expansion of Breast Tumor Samples in Culture			2002 (Cycle VIII)	$311,400
	California Pacific Medical Center Research Institute	Dairkee ,Ph.D. Shanaz
Inflammation Alters Transcription by ER in Breast Cancer			2006 (Cycle 12)	$75,051
	University of California, San Diego	Bourk ,BA Eliot
Influence of Localized DDT Exposure on Breast Cancer			2000 (Cycle VI)	$305,989
	Cedars-Sinai Medical Center	Davis ,Ph.D. Vicki
Informal and Formal Support and Needs Among Samoan Survivors			2006 (Cycle 12)	$69,682
	CSU Fullerton Auxiliary Services Corporation	Tanjasiri ,DrPH, MPH Sora
Informal and Formal Support and Needs Among Samoan Survivors			2006 (Cycle 12)	$125,039
	Samoan National Nurses Association	Mataalii ,Sala
Inhibiting Breast Cancer Brain Metastasis with Cilengitide			2010 (Cycle 16)	$284,850
	Scripps Research Institute	Felding-Habermann ,Ph.D. Brunhilde
Inhibiting Mutation to Prevent and Treat Breast Cancer			2010 (Cycle 16)	$187,438
	Scripps Research Institute	Romesberg ,Ph.D. Floyd
Inhibition of Angiogenesis in Breast Cancer			1997 (Cycle III)	$67,830
	University of California, San Francisco	Shuman ,Ph.D. Marc
Inhibition of Angiogenesis in Breast Cancer			1997 (Cycle III)	$67,830
	University of California, San Francisco	Esserman ,M.D. Laura
Inhibition of Brain Metastases in Breast Cancer			2006 (Cycle 12)	$464,750
	Scripps Research Institute	Felding-Habermann ,Ph.D. Brunhilde
Inhibition of Brain Metastases in Breast Cancer			2005 (Cycle 11)	$278,850
	Scripps Research Institute	Felding-Habermann ,Ph.D. Brunhilde
Inhibition of Breast Cancer Aggressiveness by Cannabidiol			2006 (Cycle 12)	$183,000
	California Pacific Medical Center Research Institute	McAllister ,Ph.D. Sean
Inhibition of Breast Cancer Cell Invasion by Natural Indoles			2003 (Cycle IX)	$80,000
	University of California, Berkeley	Brew ,Ph.D. Christine
Inhibition of TF Signaling as a Novel Breast Cancer Therapy			2008 (Cycle 14)	$284,250
	Scripps Research Institute	Ruf ,M.D. Wolfram
Inhibition of the BRCA2-RAD51 Interaction in Breast Cancer			2005 (Cycle 11)	$134,769
	University of California, Irvine	Zhu ,Ph.D. Jiewen
Inhibitors of Condensin I as Chemotherapy for Breast Cancer			2009 (Cycle 15)	$100,000
	University of California, Irvine	Yokomori ,Ph.D. Kyoko
Inhibitors of Myc: Novel Drugs for Breast Cancer			2003 (Cycle IX)	$277,887
	Scripps Research Institute	Vogt ,Ph.D. Peter
Inhibitors of the Breast Cancer Her-2/neu Gene			1997 (Cycle III)	$342,796
	Scripps Research Institute	Gottesfeld ,Ph.D. Joel
Integrated Proteomic and Metabolic Analysis of Breast Cancer			2005 (Cycle 11)	$59,121
	Scripps Research Institute	Chiang ,Ph.D. Kyle
Integrin Activation in the Metastasis of Breast Cancer			1997 (Cycle III)	$264
	The Burnham Institute for Medical Research	Lin ,Ph.D. Emme
Integrin Receptor Activation in Breast Cancer			1997 (Cycle III)	$71,564
	Scripps Research Institute	Rose ,D.V.M., Ph.D. David
Interactive Technology to Support Rural Women and Families			2003 (Cycle IX)	$6,667
	Northern Sierra Rural Health Network	Avram ,MPA Speranza
Interactive Technology to Support Rural Women and Families			2003 (Cycle IX)	$3,333
	Stanford University	Koopman ,Ph.D. Cheryl
Interactive Technology to Support Rural Women and Families			2003 (Cycle IX)	$3,333
	Stanford University	Kreshka ,M.A. Mary Anne
Interplay of Family Context and Ethnicity in BRCA1/2 Testing			2003 (Cycle IX)	$79,945
	University of California, Los Angeles	Glenn ,Ph.D. Beth
Intracellular Signaling by PI3K in Breast Cancer Metastasis			1998 (Cycle IV)	$43,329
	University of California, Davis	Sawai ,Ph.D. Earl
Intraductal Therapy of DCIS: A Presurgery Study			2007 (Cycle 13)	$851,559
	Dr. Susan Love Research Foundation	Love ,M.D., M.B.A. Susan
Intraoperative Assessment of Surgical Lumpectomy Margins			2006 (Cycle 12)	$268,810
	John Wayne Cancer Institute	Giuliano ,M.D. Armando
Introducing Acupuncture to Black Survivors for Wellness			2006 (Cycle 12)	$5,676
	Women of Color Breast Cancer Survivors Support Project	Tapp ,Carolyn
Introducing Acupuncture to Black Survivors for Wellness			2006 (Cycle 12)	$0
	University of California, Los Angeles	Johnston ,Ph.D. Michael
Investigation of Improved Drug Delivery in Breast Cancer			1995 (Cycle I)	$292,905
	University of California, Irvine	Nalcioglu ,Ph.D. Orhan
Isolation of Cancer Precursors from Normal Human Breasts			2006 (Cycle 12)	$45,000
	University of California, San Francisco	Liu ,Ph.D. Bob
Isolation of Estrogen Receptor Cofactors fron Breast Tumors			1995 (Cycle I)	$68,607
	University of California, San Diego	Heinzel ,Ph.D. Thorsten

K Top

Kitchen Divas: Breast Cancer Risk Reduction for Black Women			2005 (Cycle 11)	$8,000
	Black Women for Wellness	Robinson Flint ,Janette
Kitchen Divas: Breast Cancer Risk Reduction for Black Women			2005 (Cycle 11)	$2,000
	University of California, Los Angeles	Ashing-Giwa ,Ph.D. Kimlin

L Top

Laboratory Testing of Chinese Herbs Used for Breast Cancer			1999 (Cycle V)	$85,754
	University of California, San Francisco	Tripathy ,M.D. Debasish
Lasp-1 Signaling in Breast Carcinoma Cell Invasion/Migration			2001 (Cycle VII)	$85,508
	Scripps Research Institute	Lin ,Ph.D. Yi Hsing
Late Cognitive and Brain Changes After Breast Cancer Therapy			2003 (Cycle IX)	$250,000
	University of California, Los Angeles	Rausch ,M.S., Ph.D. Helen Rebecca
Latina Breast Cancer Survivors...Our Experience			2008 (Cycle 14)	$165,834
	University of California, Los Angeles	Tisnado ,M.P.A., Ph.D. Diana
Latina Breast Cancer Survivors...Our Experience			2008 (Cycle 14)	$165,834
	University of California, Los Angeles	Montano ,MPH Brian
Latinas and DCIS: Treatment Decisions and Quality of Life			2003 (Cycle IX)	$774,174
	University of California, San Francisco	Kaplan ,DrPH Celia
Leukocyte Recruitment, Angiogenesis and Breast Cancer			1998 (Cycle IV)	$304,797
	La Jolla Institute for Molecular Medicine	Sriramarao ,Ph.D. Pragada
Lifestyle Factors & Breast Ca Prognosis in Asian-Americans			2003 (Cycle IX)	$1,050,107
	University of Southern California	Wu ,Ph.D. Anna
Light at Night and Breast Cancer Risk in California Teachers			2010 (Cycle 16)	$199,080
	Cancer Prevention Institute of California	Reynolds ,Ph.D. Peggy
Linking a dietary carcinogen to breast cancer susceptibility			1996 (Cycle II)	$435,346
	Lawrence Livermore National Laboratory	Felton ,Ph.D. James
Lipid Raft Composition in Deregulated ERBB2 Signaling			2007 (Cycle 13)	$99,371
	University of California, Los Angeles	Landgraf ,Ph.D. Ralf
Living Well With Advanced Breast Cancer: A Predictive Model			2004 (Cycle 10)	$99,982
	University of California, Los Angeles	Stanton ,Ph.D. Annette
Local Adipocyte Function in Breast Cancer			2010 (Cycle 16)	$273,000
	Torrey Pines Institute for Molecular Studies	Mueller ,Ph.D. Barbara
Locating Novel Breast Cancer Genes using DNA Microarrays			2002 (Cycle VIII)	$477,295
	Stanford University	Pollack ,M.D., Ph.D. Jonathan
Loss of p53 Tumor Suppressor Function in Breast Cancer			1995 (Cycle I)	$313,848
	City of Hope National Medical Center	Momand ,Ph.D. Jamil
Loss of Tumor Suppressor Proteins in Breast Cancer Cells			1996 (Cycle II)	$69,605
	Lawrence Berkeley National Laboratory	Kim ,Ph.D. Sahn-Ho
LPC as a Potential Tumor Marker for Recurrent Breast Cancer			2001 (Cycle VII)	$100,000
	University of California, Davis	Chew ,M.D. Helen

M Top

Macrophages in Breast Cancer Patients of African Descent			2009 (Cycle 15)	$90,000
	University of California, San Francisco	Mukhtar ,M.D. Rita
Magnetic Resonance Measurement of Breast Tissue Perfusion			1995 (Cycle I)	$48,560
	University of California, Davis	Buonocore ,M.D., Ph.D. Michael
Malignant Transformation in Breast Epithelium			1995 (Cycle I)	$54,000
	Stanford University	Furthmayr ,M.D. Heinz
Mammary Cancer Gene Cooperation			1995 (Cycle I)	$372,604
	Childrens Hospital, Los Angeles	Shackleford ,Ph.D. Gregory
Mammary Gland Evaluation and Risk Assessment			2009 (Cycle 15)	$25,000
	Kaiser Foundation Research Institute	Kushi ,Sc.D. Lawrence
Mammogram Density, Cancer, Inheritance & Acquired Risk:Twins			1997 (Cycle III)	$1,265,784
	University of Southern California	Mack ,M.D., M.P.H. Thomas
Mammogram Density,Nipple Aspirate Fluid & Breast Cancer Risk			1996 (Cycle II)	$67,821
	University of California, San Francisco	Petrakis ,M.D. Nicholas
Mammographic Densities and Breast Cancer Prevention			1996 (Cycle II)	$567,993
	University of Southern California	Pike ,Ph.D. Malcolm
Mammographic Density, HRT and Hormonal Activity Genes			2000 (Cycle VI)	$708,225
	University of Southern California	Mack ,M.D., M.P.H. Thomas
Mammography Density and Sex Steroid Genes			2000 (Cycle VI)	$102,328
	University of Southern California	Ingles ,DrPH Sue Ann
Mammography Screening for Latinas with Diabetes			2006 (Cycle 12)	$92,294
	San Diego State University Research Foundation	Roussos ,PhD, MPH Stergios
Mammography Screening for Latinas with Diabetes			2006 (Cycle 12)	$110,332
	Golden Valley Health Centers	Noguera ,M.S. Christine
Marin County Breast Cancer Study of Adolescent Risk Factors			1998 (Cycle IV)	$77,407
	Marin Breast Cancer Watch	Gould-Doerr ,Mary
Marin County Breast Cancer Study of Adolescent Risk Factors			1999 (Cycle V)	$284,868
	University of California, San Francisco	Wrensch ,M.P.H., Ph.D. Margaret
Marin County Breast Cancer Study of Adolescent Risk Factors			1999 (Cycle V)	$246,800
	Marin Breast Cancer Watch	Farren ,M.D. Georgianna
Marin County Breast Cancer Study of Adolescent Risk Factors			1998 (Cycle IV)	$77,407
	University of California, San Francisco	Wrensch ,M.P.H., Ph.D. Margaret
Maspin: Breast Cancer Suppression through Enzyme Inhibition?			2004 (Cycle 10)	$196,115
	The Burnham Institute for Medical Research	Smith ,Ph.D. Jeffrey
Maternal Embryonic Leucine Zipper Kinase in Mammary Tumors			2008 (Cycle 14)	$286,500
	The Burnham Institute for Medical Research	Oshima ,Ph.D. Robert
Measurement of Breast Tissue Viscoelasticity Using MRI			1998 (Cycle IV)	$48,396
	University of California, Davis	Buonocore ,M.D., Ph.D. Michael
Measuring Real-World Breast Cancer Outcomes			2010 (Cycle 16)	$1,066,225
	Stanford University	Kurian ,M.D. Allison
Mechanism of Estrogen Receptor Loss in Breast Cancer			2003 (Cycle IX)	$17,298
	University of California, Irvine	Kang ,Ph.D. Keon Wook
Mechanism of Novel Anti-Angiogenic Therapy for Breast Cancer			1998 (Cycle IV)	$324,300
	University of Southern California	Markland ,Ph.D. Francis
Mechanism of Radiosensitivity in Breast Cancer Cells			1999 (Cycle V)	$37,200
	Scripps Research Institute	Wang ,Ph.D. Xiaofei
Mechanisms of Aberrant Cell Growth in Breast Cancer			1995 (Cycle I)	$276,643
	University of California, San Diego	Donoghue ,Ph.D. Daniel
Mechanisms of Daxx-Mediated Apoptosis in Breast Cancer			2007 (Cycle 13)	$38,000
	The Burnham Institute for Medical Research	Puto ,M.S. Lorena
Mechanisms of Fluid Transport in Human Mammary Epithelium			1999 (Cycle V)	$149,822
	University of California, Berkeley	Miller ,Ph.D. Sheldon
Mechanisms of HSP90 Inhibitor Action in Breast Cancer			2007 (Cycle 13)	$67,871
	Beckman Research Institute of the City of Hope	Wong ,B.S., B.A. Cynthie
Mechanisms of Radiation-Induced Fatigue in Breast Cancer			2000 (Cycle VI)	$224,991
	University of California, Los Angeles	Bower ,Ph.D. Julienne
Mechanisms of Reduced Metastasis by Conjugated Linoleic Acid			2000 (Cycle VI)	$314,988
	University of California, Davis	Erickson ,Ph.D. Kent
Membrane-associated Estrogen Receptors in Breast Cancer			2009 (Cycle 15)	$149,119
	University of California, Los Angeles	Pietras ,M.D., Ph.D. Richard
Metabolism of Environmental Chemicals as Breast Cancer Risk			1995 (Cycle I)	$272,029
	Lawrence Berkeley National Laboratory	Goth-Goldstein ,Ph.D. Regine
Metabolite Imaging to Identify Drug Resistant Breast Cancer			2009 (Cycle 15)	$172,237
	Lawrence Berkeley National Laboratory	Northen ,Ph.D. Trent
Metastasis Suppressor Genes for Breast Cancer			2000 (Cycle VI)	$312,937
	Stanford University	Cohen ,M.D. Stanley
Method for Measuring Breast Epithelial Turnover in Humans			2000 (Cycle VI)	$197,000
	University of California, Berkeley	Hellerstein ,M.D., Ph.D. Marc
Method to Profile Active Metalloproteases in Breast Cancer			2002 (Cycle VIII)	$85,576
	Scripps Research Institute	Joseph ,Ph.D. Arul
Migration and Breast Cancer Risk in Hispanics			2001 (Cycle VII)	$997,926
	Cancer Prevention Institute of California	John ,Ph.D. Esther
Mindful Movement Program for Breast Cancer Survivors			2008 (Cycle 14)	$124,625
	Beckman Research Institute of the City of Hope	Crane-Okada ,Ph.D., RN, CNS, AOCN Rebecca
Mindful Movement Program for Breast Cancer Survivors			2008 (Cycle 14)	$93,750
	WISE & Healthy Aging	Kiger ,R.N., M.N. Holly
MMP-Directed Synthesis of Invasive Breast Cancer Blockers			2002 (Cycle VIII)	$135,298
	Scripps Research Institute	Quaranta ,M.D. Vito
Model of Human Breast Cancer Development and Progression			1995 (Cycle I)	$300,000
	University of California, Berkeley	Nandi ,Ph.D. Satyabrata
Model-building with Complex Environmental Exposures			2009 (Cycle 15)	$282,032
	Cancer Prevention Institute of California	Nelson ,Ph.D. David
Modeling, Targeting Acetyl-CoA Metabolism in Breast Cancer			2006 (Cycle 12)	$90,000
	The Burnham Institute for Medical Research	Yang ,Ph.D. Chen
Modulation of Breast Cancer Stem Cell Response to Radiation			2007 (Cycle 13)	$149,377
	University of California, Los Angeles	Pajonk ,M.D., Ph.D. Frank
Modulation of Breast Cancer Stem Cell Response to Radiation			2009 (Cycle 15)	$250,000
	University of California, Los Angeles	Pajonk ,M.D., Ph.D. Frank
Modulation of Drug Resistance by Protein Kinase C Inhibitors			1997 (Cycle III)	$24,182
	Stanford University	Lu ,Ph.D. Yuefeng
Modulation of TGF-beta Signaling in Mammary Epithelial Cells			2005 (Cycle 11)	$73,723
	University of California, Irvine	Xu ,B.S. Xiaoman
Molecular Analysis of BRCA1 Function			2003 (Cycle IX)	$85,557
	Salk Institute for Biological Studies	Zhu ,Ph.D. Quan
Molecular Analysis of BRCA1 Function			1997 (Cycle III)	$75,045
	Salk Institute for Biological Studies	Chapman ,Ph.D. Mark
Molecular Analysis of DCIS Progression in a Mouse Model			2003 (Cycle IX)	$80,000
	University of California, Davis	Namba ,Ph.D. Ruria
Molecular Characterization of ErbB2 Positive Breast Cancers			2001 (Cycle VII)	$86,200
	Buck Institute for Age Research	Neve ,Ph.D. Richard
Molecular classification of early breast neoplasia			2011 (Cycle 17)	$158,000
	Stanford University	West ,M.D., Ph.D. Robert
Molecular control of breast exposure to selenium			1996 (Cycle II)	$124,870
	University of California, San Diego	Howell ,M.D. Stephen
Molecular Design for Prevention of Breast Cancer Progression			1995 (Cycle I)	$661,487
	Cancer Research Institute of Contra Costa	Peterson ,Ph.D. Jerry
Molecular Imaging of Breast Cancer Using Breast PET/CT			2005 (Cycle 11)	$99,907
	University of California, Davis	Badawi ,Ph.D. Ramsey
Molecular Imaging of Metastatic Lymph Nodes in Breast Cancer			2007 (Cycle 13)	$149,600
	University of California, San Francisco	Jones ,Ph.D. Ella
Molecular Karyotyping of Breast Cancer by DNA Fingerprinting			1997 (Cycle III)	$290,550
	The Burnham Institute for Medical Research	Malkhosyan ,Ph.D. Sergei
Molecular Mapping of Surgical Margins			1998 (Cycle IV)	$287,992
	California Pacific Medical Center Research Institute	Dairkee ,Ph.D. Shanaz
Molecular mechanisms of EGF receptor endocytosis			1996 (Cycle II)	$69,685
	University of California, San Diego	Nesterov ,Ph.D. Alexander
Molecular Pathogenesis of Metastatic Breast Cancer			2002 (Cycle VIII)	$311,367
	California Pacific Medical Center Research Institute	Debs ,M.D. Robert
Molecular Staging of Breast Cancer Progression			2000 (Cycle VI)	$244,320
	University of Southern California	Chuong ,M.D., Ph.D. Cheng-Ming
Molecular Structure of BAG-1:a New Protein in Breast Cancer			1999 (Cycle V)	$291,778
	The Burnham Institute for Medical Research	Ely ,Ph.D. Kathryn
Molecular Study of BAG Domains: A New Motif in Breast Cancer			2001 (Cycle VII)	$49,869
	The Burnham Institute for Medical Research	Briknarova ,Ph.D. Klara
Mouse model for the loss of Bax expression in breast cancer			1996 (Cycle II)	$385,198
	The Burnham Institute for Medical Research	Baribault ,Ph.D. Helene
MRI Detection of Breast Cancer Blood Vessels			1997 (Cycle III)	$149,935
	University of California, Irvine	Nalcioglu ,Ph.D. Orhan
MRI Detection of Microvascular Status in Breast Cancer			1995 (Cycle I)	$299,736
	University of California, San Francisco	Brasch ,M.D. Robert
MRI for High Risk Breast Cancer Screening and Surveillance			2000 (Cycle VI)	$499,630
	University of California, San Francisco	Hylton ,Ph.D. Nola
MRI for High Risk Breast Cancer Screening and Surveillance			2000 (Cycle VI)	$499,630
	University of California, San Francisco	Ziegler ,M.D., M.Sc. John
MRI for High Risk Breast Cancer Screening and Surveillance			2000 (Cycle VI)	$499,630
	University of California, San Francisco	Hwang ,M.D. Shelley
MRI Guided Focused Ultrasound in Breast Cancer Treatment			2010 (Cycle 16)	$88,467
	Stanford University	Bitton ,Ph.D. Rachel
MRI Registration for Therapy Evaluation and Annual Screening			2010 (Cycle 16)	$76,000
	University of California, Irvine	Lin ,M.S. Muqing
Multi-ethnic Study of Genetic Control of Plasma Hormones			1998 (Cycle IV)	$141,639
	University of Southern California	Feigelson ,Ph.D., M.P.H. Heather
Multilingual Access to Breast Cancer Early Detection			2006 (Cycle 12)	$10,000
	Alameda County Health Care Foundation	Stewart ,Ph.D. Susan
Multilingual Access to Breast Cancer Early Detection			2006 (Cycle 12)	$10,000
	Alameda County Health Care Foundation	Engelstad ,M.D. Linda
Multimarker miR Blood Assay for Breast Cancer Detection			2010 (Cycle 16)	$275,529
	John Wayne Cancer Institute	Hoon ,MSc, Ph.D. David
Multinuclear MRI of Breast Tumors			2007 (Cycle 13)	$236,771
	Stanford University	Hargreaves ,Ph.D. Brian
MYC and CSN5 in the Breast Cancer "Wound Signature" Profile			2006 (Cycle 12)	$76,000
	Stanford University	Adler ,BA Adam
Myeloperoxidase Mediated Protection in Breast Cancer			2010 (Cycle 16)	$286,500
	The Burnham Institute for Medical Research	Reynolds ,Ph.D. Wanda

N Top

Nail Salon Workers: Chemical Exposures in the Workplace			2008 (Cycle 14)	$25,000
	Asian Health Services	Okahara ,Linda
Nanolipoproteins to Study Breast Cancer Growth Receptors			2008 (Cycle 14)	$99,000
	University of California, Davis	Henderson ,Ph.D. Paul
Nanotherapy for Breast Cancer Targeting Tumor Macrophages			2008 (Cycle 14)	$90,000
	The Burnham Institute for Medical Research	Sharma ,Ph.D. Gaurav
NCCC Breast Cancer Research Training Program			1998 (Cycle IV)	$339,527
	University of Southern California	Ross ,M.D. Ronald
Neighborhood Environment and Obesity in Pre-adolescent Girls			2006 (Cycle 12)	$162,847
	University of California, San Francisco	Yen ,Ph.D. Irene
Neighborhoods and Obesity in Pre-adolescent Girls: Part II			2008 (Cycle 14)	$214,406
	University of California, San Francisco	Yen ,Ph.D. Irene
Networking Breast Cancer Navigator Programs in N California			2007 (Cycle 13)	$10,509
	Alta Bates Summit Medical Foundation	Bailey ,M.D., F.A.C.S. Lisa
Neural Stem Cell Therapy for Breast Cancer Brain Metastases			2006 (Cycle 12)	$302,085
	Scripps Research Institute	Felding-Habermann ,Ph.D. Brunhilde
Neural Stem Cell Therapy for Breast Cancer Brain Metastases			2007 (Cycle 13)	$419,400
	Scripps Research Institute	Felding-Habermann ,Ph.D. Brunhilde
New Breast Cancer Approaches: Integration, Communication			2005 (Cycle 11)	$150,000
	University of California, San Francisco	Karliner ,M.D. Leah
New Endocrine Strategy to Prevent Breast Cancer Progression			1995 (Cycle I)	$263,080
	University of California, Los Angeles	Pietras ,M.D., Ph.D. Richard
New Estrogen Receptor Downregulators for Breast Cancer			2010 (Cycle 16)	$150,000
	University of California, Los Angeles	Pietras ,M.D., Ph.D. Richard
New Imager to Improve Specificity in Breast Cancer Detection			2002 (Cycle VIII)	$215,191
	Lawrence Livermore National Laboratory	Hartmann Siantar ,Ph.D. Christine
New Imager to Improve Specificity in Breast Cancer Detection			2002 (Cycle VIII)	$215,191
	Lawrence Livermore National Laboratory	DeNardo ,M.D. Gerald
New Imager to Improve Specificity in Breast Cancer Detection			2002 (Cycle VIII)	$215,191
	Lawrence Livermore National Laboratory	Vetter ,Ph.D. Kai
New imaging Modality for Early Detection of Breast Cancer			1997 (Cycle III)	$149,500
	University of California, Los Angeles	Pardridge ,M.D. William
New Imaging Modality for Early Detection of Breast Cancer			1995 (Cycle I)	$49,516
	University of California, Los Angeles	Pardridge ,M.D. William
New Method for Measuring Breast Cancer Gene Expression			1995 (Cycle I)	$85,706
	Lawrence Berkeley National Laboratory	Pinkel ,Ph.D. Daniel
New Methods for Genomic Studies in African American Women			2009 (Cycle 15)	$442,631
	University of Southern California	Stram ,Ph.D. Daniel
New Paradigm of Breast Cancer Causation and Prevention			2009 (Cycle 15)	$229,732
	University of California, San Francisco	Hiatt ,M.D., Ph.D. Robert
New Radiation Therapy for HER-2-overexpressing Breast Cancer			1999 (Cycle V)	$200,000
	University of California, Los Angeles	Pietras ,M.D., Ph.D. Richard
New Technology to Enhance PET Imaging of Breast Cancer			2006 (Cycle 12)	$154,879
	Stanford University	Levin ,Ph.D. Craig
Nitric Oxide and Arginine in Normal and Tumorous Breast			1999 (Cycle V)	$200,000
	University of California, San Diego	MacLeod ,Ph.D. Carol
Nitric Oxide's Role in Breast Cancer Metabolism and Growth			1997 (Cycle III)	$74,000
	City of Hope National Medical Center	Balon ,Ph.D. Thomas
Nongenomic actions of antiestrogens			1996 (Cycle II)	$495,150
	John Wayne Cancer Institute	Cabot ,Ph.D. Myles
Non-Invasive Optical Characterization of Breast Physiology			2000 (Cycle VI)	$499,915
	University of California, Irvine	Tromberg ,Ph.D. Bruce
Non-Invasive Optical Characterization of Breast Physiology			2000 (Cycle VI)	$499,915
	University of California, Irvine	Butler ,M.D. John
Non-Invasive Optical Detection of Breast Cancer			1996 (Cycle II)	$50,000
	University of California, Irvine	Tromberg ,Ph.D. Bruce
Normal Mammary Biology of Phosphorylated Prolactin			2004 (Cycle 10)	$541,444
	University of California, Riverside	Walker ,Ph.D. Ameae
Novel Agent for Lymph Node Imaging and Targeted Gene Therapy			1996 (Cycle II)	$40,912
	University of California, Davis	Wisner ,D.V.M. Erik
Novel Agents for Treatment of Advanced Breast Cancer			2000 (Cycle VI)	$388,866
	SRI International	Jong ,Ph.D. Ling
Novel Akt Regulatory Factor PHLPP in Breast Cancer			2009 (Cycle 15)	$0
	University of California, San Diego	Warfel ,M.S. Noel
Novel Anti-Angiogenic Agents for Breast Cancer Therapy			2000 (Cycle VI)	$366,022
	SRI International	Laderoute ,Ph.D. Keith
Novel Anti-HER2 Fragments for Better Detection and Therapy			2008 (Cycle 14)	$38,000
	University of California, Los Angeles	Sirk ,BA Shannon
Novel Anti-vascular Agents for Breast Cancer Therapy			1998 (Cycle IV)	$353,908
	SRI International	Laderoute ,Ph.D. Keith
Novel Approach to Analyze Estrogen Action in Breast Cancer			2005 (Cycle 11)	$310,950
	La Jolla Institute for Molecular Medicine	Eliceiri ,Ph.D. Brian
Novel Binding Functions of Mutant p53 in Breast Cancer Cells			1998 (Cycle IV)	$68,889
	Lawrence Berkeley National Laboratory	Itahana ,Ph.D. Koji
Novel Breast Cancer Anti-Angiogenic Compounds			1999 (Cycle V)	$67,611
	University of California, Los Angeles	Brooks ,M.D., FACS Mai
Novel Breast Cancer Epithelial Cell Metalloproteinase			1997 (Cycle III)	$193,995
	California Pacific Medical Center Research Institute	Desprez ,Ph.D. Pierre-Yves
Novel Cell-matrix Markers and Drivers of Breast Cancer			2011 (Cycle 17)	$262,500
	California Pacific Medical Center Research Institute	Muschler ,Ph.D. John
Novel Cytokine Immunotherapy for Breast Cancer			2007 (Cycle 13)	$150,000
	University of California, San Diego	Goldrath ,Ph.D. Ananda
Novel drugs to inhibit breast cancer metastasis			1997 (Cycle III)	$197,064
	University of California, Santa Cruz	Konopelski ,Ph.D. Joseph
Novel Enzyme Inhibitors for Estrogen-Dependent Breast Cancer			1997 (Cycle III)	$364,820
	SRI International	Tanabe ,Ph.D. Masato
Novel Enzymes Associated with Breast Cancer Angiogensis			2001 (Cycle VII)	$100,000
	University of California, San Francisco	Rosen ,Ph.D. Steven
Novel Genes in Mammary Gland Development and Cancer			2003 (Cycle IX)	$80,000
	University of California, San Francisco	Slorach ,Ph.D. Euan
Novel I3C Regulated Cell Cycle Factor in Breast Cancer Cells			2003 (Cycle IX)	$150,000
	University of California, Berkeley	Firestone ,Ph.D. Gary
Novel Inhibitors of Rad51-DNA Repair in Breast Cancer			2001 (Cycle VII)	$130,332
	Pangene Corporation	Vallerga ,Ph.D. Anne
Novel Ligands as Probes of Estrogen Receptor Signaling			2002 (Cycle VIII)	$50,941
	University of California, San Francisco	Clegg ,Nicola
Novel Mechanisms of ErbB-2-Mediated Breast Cancer Metastasis			2000 (Cycle VI)	$257,006
	Scripps Research Institute	Klemke ,Ph.D. Richard
Novel PET cameras for Earlier Detection of Breast Cancer			1995 (Cycle I)	$446,093
	Lawrence Berkeley National Laboratory	Moses ,Ph.D. William
Novel Regulation of the Rb Pathway in Breast Epithelium			2007 (Cycle 13)	$74,808
	Stanford University	Burkhart ,Ph.D. Deborah
Novel retinoids that induce apoptosis in breast cancer cells			1996 (Cycle II)	$377,091
	Sidney Kimmel Cancer Center	Pfahl ,Ph.D. Magnus
Novel Retinoids with Enhanced Anti-Breast Tumor Efficacy			2002 (Cycle VIII)	$378,972
	The Burnham Institute for Medical Research	Dawson ,Ph.D. Marcia
Novel Small Proteins for PET Imaging of Breast Cancer			2008 (Cycle 14)	$261,806
	Stanford University	Cheng ,Ph.D. Zhen
Novel Technologies to Identify Tissue-Selective Estrogens			2001 (Cycle VII)	$75,000
	University of California, San Francisco	Schaufele ,Ph.D. Fred
Novel Tumor Suppressors in Breast Development and Cancer			2009 (Cycle 15)	$231,058
	Stanford University	Fuller ,Ph.D. Margaret
Novel Ways to Control the Growth of Mammary Epithelial Cells			1996 (Cycle II)	$35,256
	Scripps Research Institute	Koch ,Ph.D. Susanne
Nuevo Amanecer: Promoting the Psychosocial Health of Latinas			2009 (Cycle 15)	$313,067
	Circulo de Vida Cancer Support and Resource Center	Ortiz ,Ph.D. Carmen
Nuevo Amanecer: Promoting the Psychosocial Health of Latinas			2009 (Cycle 15)	$349,547
	University of California, San Francisco	Napoles-Springer ,Ph.D., MPH Anna
Nur77-derived Peptides as a Novel Breast Cancer Therapy			2006 (Cycle 12)	$286,108
	The Burnham Institute for Medical Research	Zhang ,Ph.D. Xiao-Kun

O Top

Oncogene Regulation in Mammary Cancer			1996 (Cycle II)	$616,191
	The Burnham Institute for Medical Research	Oshima ,Ph.D. Robert
Oncogenes, Progression and Biomarkers			1999 (Cycle V)	$141,871
	University of California, Davis	Cardiff ,M.D., Ph.D. Robert
Optical Spectroscopic Detection and Imaging of Breast Cancer			2001 (Cycle VII)	$0
	Lawrence Livermore National Laboratory	Demos ,Ph.D. Stavros
Optical Spectroscopic Detection and Imaging of Breast Cancer			2001 (Cycle VII)	$99,513
	University of California, Davis	Ramsamooj ,M.D. Rajen
Optical Spectroscopic Detection and Imaging of Breast Cancer			2001 (Cycle VII)	$99,513
	University of California, Davis	Demos ,Ph.D. Stavros
Oral Contraceptives, Hormonal Risk Factors and BRCA1			1998 (Cycle IV)	$1,693,685
	University of Southern California	Ursin ,M.D., Ph.D. Giske
Organochlorine Insecticides and Breast Cancer			1997 (Cycle III)	$106,412
	University of California, Davis	Enan ,Ph.D. Essam
Outpatient Stem Cell Transplants for Breast Cancer			1996 (Cycle II)	$0
	Scripps Clinic & Research Foundation	Meisenberg ,M.D. Barry
Outpatient Stem Cell Transplants for Breast Cancer			1996 (Cycle II)	$189,970
	University of California, San Diego	Hollenbach ,M.P.H, Ph.D. Kathryn
Overcoming Drug Resistance in Breast Cancer			2001 (Cycle VII)	$378,529
	The Burnham Institute for Medical Research	Vuori ,M.D., Ph.D. Kristiina
Overcoming Tamoxifen-resistance in Breast Cancer			2003 (Cycle IX)	$281,370
	The Burnham Institute for Medical Research	Vuori ,M.D., Ph.D. Kristiina
Oxidative Stress and Estrogen Receptor Structural Changes			2004 (Cycle 10)	$1,122,520
	Buck Institute for Age Research	Gibson ,Ph.D. Bradford
Oxidative Stress and Estrogen Receptor Structural Changes			2004 (Cycle 10)	$1,122,520
	Buck Institute for Age Research	Benz ,M.D. Christopher

P Top

P132Cas and Antiestrogen Resistance of Breast Cancer			2001 (Cycle VII)	$42,660
	The Burnham Institute for Medical Research	Rehn ,Ph.D. Marko
P32: New Functional Target in Breast Cancer Brain Metastasis			2009 (Cycle 15)	$71,577
	Scripps Research Institute	Staflin ,Ph.D Karin
p97 as a Therapeutic Target in Breast Cancer Metastasis			2010 (Cycle 16)	$292,500
	Proteomics Research Institute for Systems Medicine	Latterich ,Ph.D. Martin
Partnership to Advance Breast Cancer Research			2010 (Cycle 16)	$1,103,827
	University of California, San Francisco	Woodruff ,Tracey
Partnership to Reduce Cancer Disparities in Spanish Speakers			2005 (Cycle 11)	$55,502
	University of California, San Francisco	Pasick ,DrPH Rena
Partnership to Reduce Cancer Disparities in Spanish Speakers			2005 (Cycle 11)	$55,373
	Women's Cancer Resource Center	McGuire ,Peggy
Pathway-Specific Gene Expression in Breast Cancer Cells			2001 (Cycle VII)	$339,287
	University of California, Davis	Sweeney ,Ph.D. Colleen
Patient and Clinician Knowledge of Breast Cancer Lymphedema			2009 (Cycle 15)	$227,784
	Kaiser Foundation Research Institute	Kwan ,Ph.D. Marilyn
Patient-Individualized Chemotherapy in Breast Cancer			2001 (Cycle VII)	$296,994
	University of California, Los Angeles	Silverman ,M.D., Ph.D. Daniel
PBDEs in Tissues of Women With and Without Breast Cancer			2004 (Cycle 10)	$67,779
	Public Health Institute	Petreas ,Ph.D., M.P.H. Myrto
Peer Mentoring Program in Breast Cancer Clinical Research			2003 (Cycle IX)	$10,000
	Long Beach Memorial Medical Center	Rakoff ,Michele
Peer Mentoring Program in Breast Cancer Clinical Research			2003 (Cycle IX)	$10,000
	Long Beach Memorial Medical Center	Link ,M.D. John
Peer Mentors Promoting Breast Cancer Clinical Research			2004 (Cycle 10)	$47,710
	Long Beach Memorial Medical Center	Rakoff ,Michele
Peer Mentors Promoting Breast Cancer Clinical Research			2004 (Cycle 10)	$47,710
	Long Beach Memorial Medical Center	Link ,M.D. John
Peer Mentors Promoting Breast Cancer Clinical Research			2004 (Cycle 10)	$22,942
	University of California, Los Angeles	Maxwell ,DrPH Annette
Peptide Vaccines for Immunoprevention of Breast Cancer			1995 (Cycle I)	$299,886
	University of California, San Diego	Kipps ,M.D., Ph.D. Thomas
Peptide-pulsed Dendritic Cell Therapy for Breast Cancer			1997 (Cycle III)	$293,506
	University of Southern California	Weber ,M.D., Ph.D. Jeffrey
Persistent Organic Pollutants & Breast Cancer Risk			2010 (Cycle 16)	$4,850,028
	Cancer Prevention Institute of California	Reynolds ,Ph.D. Peggy
Pesticide and Gene Interactions in Latina Farm Workers			2008 (Cycle 14)	$160,718
	University of California, San Francisco	Mills ,Ph.D., MPH Paul
Pesticides and Breast Cancer in Hispanic Women			2001 (Cycle VII)	$299,397
	Public Health Institute	Mills ,Ph.D., MPH Paul
Pharmacological Modulation of PP2A Activity in Breast Cancer			2010 (Cycle 16)	$29,366
	Scripps Research Institute	Bachovchin ,A.B. Daniel
Physical Activity and Diet in Adolescents with Disabilities			2000 (Cycle VI)	$84,366
	California State University, Northridge	Koprowski ,Ph.D., R.D. Carol
Physical Activity and Diet in Adolescents with Disabilities			2000 (Cycle VI)	$84,366
	California State University, Northridge	Hall ,Ph.D. Katherine
Physical Activity, Diet and Menarche in a Multiethnic Cohort			1997 (Cycle III)	$75,546
	University of Southern California	Koprowski ,Ph.D., R.D. Carol
Physical Activity: Impact on Hormones and Breast Cancer Risk			1995 (Cycle I)	$60,023
	University of Southern California	Carpenter ,M.P.H., Ph.D. Catherine
Pilot Studies of Breast Cancer Immunophototherapy			2003 (Cycle IX)	$99,834
	University of California, Irvine	Nelson ,M.D. Edward
Platelet factor 4: A Marker For Malignant Breast Tumors			1995 (Cycle I)	$95,380
	La Jolla Institute for Molecular Medicine	Borgstrom ,Ph.D. Per
Podocalyxin as a Basal-like Breast Cancer Stem Cell Marker			2009 (Cycle 15)	$243,676
	University of Southern California	Casey ,Ph.D. Graham
Polyamide Inhibitors to Block Estrogen Receptor Function			2007 (Cycle 13)	$75,600
	California Institute of Technology	Phillips ,M.S. John
Postmenopausal Breast Cancer: Obesity & the Leptin Receptor			1999 (Cycle V)	$97,677
	University of Southern California	Bernstein ,Ph.D. Leslie
Potential New Drug Therapy for Breast Cancer			2002 (Cycle VIII)	$199,740
	University of California, San Francisco	Youngren ,Ph.D. Jack
Potential Role of a Novel Repressor Complex in Breast Cancer			2002 (Cycle VIII)	$0
	University of California, San Diego	Liu ,M.D., Ph.D. JianXiang
Potential Tumor Suppressors in Breast Cancer			1996 (Cycle II)	$69,361
	University of California, San Diego	Treier ,Ph.D. Mathias
PPAR Modulators as Apoptosis Sensitizers for Breast Cancer			2002 (Cycle VIII)	$456,924
	The Burnham Institute for Medical Research	Reed ,M.D., Ph.D. John
PPARd Ligands for Inhibition of Breast Cancer Progression			2001 (Cycle VII)	$192,842
	SRI International	Murphy ,Ph.D. Brian
Pre-clinical cryosurgery testing in breast cancer treatment			1996 (Cycle II)	$200,000
	University of California, Berkeley	Rubinsky ,Ph.D. Boris
Preclinical Trials for Breast Cancer			2003 (Cycle IX)	$25,000
	University of California, Davis	Cardiff ,M.D., Ph.D. Robert
Prediction of Compliance and Retention in High Risk Patients			1998 (Cycle IV)	$69,555
	University of California, Los Angeles	Lindberg ,Ph.D. Nangel
Predictors of Recurrent Breast Tumors in Women with DCIS			1996 (Cycle II)	$372,771
	University of California, San Francisco	Kerlikowske ,M.S., M.D. Karla
Pregnancy and Breast Cancer: an Immunological Connection?			2000 (Cycle VI)	$74,600
	University of California, San Francisco	Campbell ,Ph.D. Michael
Preventing Breast Cancer with Ginseng			2003 (Cycle IX)	$99,708
	University of California, Davis	DeGregorio ,Pharm.D. Michael
Prevention of Breast Cancer by Blocking Integrin Function			1995 (Cycle I)	$545,057
	The Burnham Institute for Medical Research	Smith ,Ph.D. Jeffrey
Prevention of Breast Cancer Tumor Growth by Retinoic Acid			1995 (Cycle I)	$10,310
	The Burnham Institute for Medical Research	Liu ,Ph.D. Yi
Profiling Drug Metabolism (P450) Proteins in Breast Cancer			2006 (Cycle 12)	$105,147
	Scripps Research Institute	Wright ,Ph.D. Aaron
Profiling Enzyme Activities in Human Breast Cancer			2004 (Cycle 10)	$400,000
	Stanford University	Jeffrey ,M.D. Stefanie
Profiling Enzyme Activities in Human Breast Cancer			2004 (Cycle 10)	$464,906
	Scripps Research Institute	Cravatt ,Ph.D. Benjamin
Profiling Enzyme Activities in Models of Human Breast Cancer			2002 (Cycle VIII)	$369,508
	Scripps Research Institute	Cravatt ,Ph.D. Benjamin
Profiling of Tyrosine Phosphatases in Breast Cancer			2000 (Cycle VI)	$133,392
	University of California, Davis	Tepper ,Ph.D. Clifford
Profiling Serine Protease Activities in Breast Cancer			2000 (Cycle VI)	$265,950
	Scripps Research Institute	Cravatt ,Ph.D. Benjamin
Progesterone Action in Human Breast Cancer			1995 (Cycle I)	$85,733
	Lawrence Berkeley National Laboratory	Harris ,Ph.D. G. Shyamala
Progesterone Receptor and Remodeling of Basement Membrane			1998 (Cycle IV)	$120,681
	Lawrence Berkeley National Laboratory	Harris ,Ph.D. G. Shyamala
Prognostic Implications of DNA Glycation in Breast Cancer			2008 (Cycle 14)	$67,060
	Beckman Research Institute of the City of Hope	Tamae ,Ph.D. Daniel
Prognostic Value of Ras Activation in Breast Cancer			2002 (Cycle VIII)	$498,596
	University of California, San Diego	Boss ,M.D. Gerry
Prognostic Value of Ras Activation in Breast Cancer			2002 (Cycle VIII)	$498,596
	University of California, San Diego	Wallace ,M.D. Anne
Prolactin and Breast Cancer Risk in a Multiethnic Cohort			2003 (Cycle IX)	$160,843
	University of Southern California	Henderson ,M.D. Brian
Proline Metabolism in Metastatic Breast Cancer			2009 (Cycle 15)	$284,895
	The Burnham Institute for Medical Research	Richardson ,Ph.D. Adam
Promoting Early Detection of Breast Cancer Among Vietnamese			1995 (Cycle I)	$298,870
	University of California, San Francisco	McPhee ,M.D. Steve
Proper relocation of a tumor suppressor in Breast Cancer			1996 (Cycle II)	$50,000
	University of California, Irvine	Waterman ,Ph.D. Marian
Protease Fingerprinting to Diagnose Breast Cancer			1999 (Cycle V)	$285,405
	The Burnham Institute for Medical Research	Smith ,Ph.D. Jeffrey
Protective Role of Estrogen Receptor Beta in Mammary			2004 (Cycle 10)	$90,000
	University of California, San Francisco	Hodges Gallagher ,Ph.D. Leslie
Protein Factor PPARg & Vitamin A Compounds in Breast Cancer			2001 (Cycle VII)	$85,218
	The Burnham Institute for Medical Research	James ,Ph.D. Sharon
Protein Markers in Nipple Aspirates for Breast Cancer			2000 (Cycle VI)	$199,019
	University of California, Los Angeles	Chang ,M.D., Ph.D. Helena
Proteolysis of Cyclin E in Normal and Malignant Breast Cells			1999 (Cycle V)	$31,582
	Scripps Research Institute	Strohmaier ,Ph.D. Heimo
Proteomic Profiling of Adhesive Structures in Breast Cancer			2004 (Cycle 10)	$90,000
	The Burnham Institute for Medical Research	Bush ,Ph.D. Jason
Provider Communication and Health in Breast Cancer Survivors			2008 (Cycle 14)	$65,744
	University of California, Berkeley	Fernandes-Taylor ,BA Sara
Psychobiological Concomitants: Bereaved Women at Br Ca Risk			2004 (Cycle 10)	$94,738
	University of California, Los Angeles	Wellisch ,Ph.D. David
Psychosocial Support Services for Latinas with Breast Cancer			2005 (Cycle 11)	$99,200
	University of California, San Francisco	Ortiz ,Ph.D. Carmen
Psychosocial Support Services for Latinas with Breast Cancer			2005 (Cycle 11)	$99,200
	University of California, San Francisco	Napoles-Springer ,Ph.D., MPH Anna

Q Top

Quality of Mammography Facilities Serving Vulnerable Women			2010 (Cycle 16)	$239,673
	University of California, San Francisco	Goldman ,M.D. Lauren
Quality of Mammography Facilities Serving Vulnerable Women			2008 (Cycle 14)	$150,000
	University of California, San Francisco	Goldman ,M.D. Lauren

R Top

Rac/STAT5 Signaling			2002 (Cycle VIII)	$79,824
	The Burnham Institute for Medical Research	Choi ,Ph.D. Hee Kwang
Race & Ethnicity in Stage-specific Breast Cancer Survival			2009 (Cycle 15)	$32,953
	Beckman Research Institute of the City of Hope	Henderson ,Ph.D. Katherine DeLellis
Race & Ethnicity in Stage-specific Breast Cancer Survival			2009 (Cycle 15)	$26,943
	University of Southern California	Monroe ,Ph.D. Kristine
Race & Ethnicity in Stage-specific Breast Cancer Survival			2009 (Cycle 15)	$30,946
	Beckman Research Institute of the City of Hope	Bernstein ,Ph.D. Leslie
Race & Ethnicity in Stage-specific Breast Cancer Survival			2009 (Cycle 15)	$166,000
	University of Southern California	Wu ,Ph.D. Anna
Race & Ethnicity in Stage-specific Breast Cancer Survival			2009 (Cycle 15)	$28,037
	Cancer Prevention Institute of California	John ,Ph.D. Esther
Race & Ethnicity in Stage-specific Breast Cancer Survival			2009 (Cycle 15)	$30,431
	Kaiser Foundation Research Institute	Kwan ,Ph.D. Marilyn
Race/Ethnicity and Late Stage Breast Cancer			1995 (Cycle I)	$123,127
	University of Southern California	Delgado ,Ph.D., M.P.H. David
Race/Ethnicity, Socioeconomic Status and Breast Cancer			2000 (Cycle VI)	$38,258
	Public Health Institute	Wright ,Ph.D. William
Racial Disparity in Breast Cancer Mortality			2003 (Cycle IX)	$580,887
	University of California, San Francisco	Smith-Bindman ,M.D. Rebecca
rADDs: Novel Disintegrins Targeting Breast Cancer			2006 (Cycle 12)	$244,500
	University of Southern California	Swenson ,Ph.D. Stephen
Radiation, Reproductive & Menstrual Factors & Breast Cancer			1998 (Cycle IV)	$60,604
	University of Southern California	Hill ,Ph.D. Deirdre
Radiosurgery of early breast cancer			1996 (Cycle II)	$76,713
	University of Southern California	Formenti ,M.D. Silvia
Reactivation of the Inactive X Chromosome and Breast Cancer			2005 (Cycle 11)	$48,563
	University of California, San Francisco	Andersen ,Ph.D. Angela
Real Time Telemanagement of Mammography Examinations			1995 (Cycle I)	$299,757
	University of California, San Francisco	Huang ,D.Sc. H.
Real-Time 3D Ultrasound Image-Guidance for Breast Surgery			2006 (Cycle 12)	$66,141
	Stanford University	Bax ,M.S. Michael
Receptor Antibody-Enhanced Chemotherapy for Breast Cancer			1997 (Cycle III)	$347,674
	Beckman Research Institute of the City of Hope	Fujita-Yamaguchi ,Ph.D. Yoko
Receptor Re-expression in ER and PR Negative Breast Cancer			2010 (Cycle 16)	$243,000
	University of Southern California	Garcia ,M.D. Agustin
Recombination and Mutation in Breast Cancer			1997 (Cycle III)	$260,988
	Pangene Corporation	Zarling ,Ph.D. David
Recording medical visits for people with breast cancer			2010 (Cycle 16)	$637,500
	University of California, San Francisco	Belkora ,Ph.D. Jeffrey
Recording medical visits for people with breast cancer			2010 (Cycle 16)	$637,500
	University of California, San Francisco	O'Donnell ,Sara
Reduced Breast Cancer Metastasis by Conjugated Linoleic Acid			1998 (Cycle IV)	$199,627
	University of California, Davis	Erickson ,Ph.D. Kent
Reducing Disparities among Korean American Women			2003 (Cycle IX)	$70,943
	University of California, Los Angeles	Maxwell ,DrPH Annette
Reducing Disparities among Korean-American Women			2003 (Cycle IX)	$36,321
	Korean Health, Education, Information and Research Cntr	Chin ,Ph.D. Soo-Young
Reducing Surgical Morbidity of Breast Cancer Staging			2009 (Cycle 15)	$149,983
	University of California, Davis	Chen ,M.D. Steven
Reducing Surgical Morbidity of Breast Cancer Staging			2011 (Cycle 17)	$444,942
	Beckman Research Institute of the City of Hope	Chen ,M.D. Steven
Reelin Signaling Involvement in Breast Cancer Cell Migration			2010 (Cycle 16)	$149,493
	University of California, Los Angeles	Carpenter ,Ph.D. Ellen
Regaining Control over Breast Cancer Cells			1995 (Cycle I)	$270,132
	University of California, San Diego	Karin ,Ph.D. Michael
Regulation of Breast Epithelial Cell Motility by Proteases			1998 (Cycle IV)	$464,030
	Scripps Research Institute	Quaranta ,M.D. Vito
Regulation of Breast Stem-Progenitor Cell Chromatin by Pygo2			2008 (Cycle 14)	$135,000
	University of California, Irvine	Gu ,Ph.D. Bingnan
Regulation of Estrogen Response by Corepressors			2002 (Cycle VIII)	$149,942
	University of California, Davis	Privalsky ,Ph.D. Martin
Regulation of Mammary Epithelial Invasion by MMPs and FGFs			2005 (Cycle 11)	$135,000
	University of California, San Francisco	Ewald ,Ph.D. Andrew
Regulation of SXR and Drug Resistance in Breast Cancer			2002 (Cycle VIII)	$41,984
	Beckman Research Institute of the City of Hope	Murray ,BA Jennifer
Regulation of the ATR Checkpoint Response in Breast Cancer			2001 (Cycle VII)	$86,297
	Stanford University	Yean ,Ph.D. Dawn
Regulation of the Rad1 Checkpoint Complex in Breast Cancer			2002 (Cycle VIII)	$59,987
	Stanford University	Lupardus ,B.S. Patrick
Regulation of Wnt: Clues for breast cancer pathognesis			1997 (Cycle III)	$13,849
	University of California, Irvine	Theisen ,Ph.D. Heidi
Regulatory Mechanisms for Growth & Motility in Breast Cancer			1995 (Cycle I)	$82,900
	Scripps Research Institute	Knaus ,Ph.D. Ulla
Removing Respiratory Artifacts in Nuclide Breast Imaging			2005 (Cycle 11)	$31,556
	Stanford University	Thorndyke ,Ph.D. Brian
Reproductive Concerns and Depression among Younger Survivors			2008 (Cycle 14)	$34,617
	University of California, San Diego	Gorman ,M.P.H. Jessica
Reprogramming Breast Cancer Epithelial Cells			1997 (Cycle III)	$97,500
	The Burnham Institute for Medical Research	Frisch ,Ph.D. Steven
Retinoids in Combination Therapies against Breast Cancer			2002 (Cycle VIII)	$389,000
	Sidney Kimmel Cancer Center	Piedrafita ,Ph.D. F. Javier
Return to Work after Breast Cancer Surgery			2001 (Cycle VII)	$625,000
	Women's Cancer Resource Center	Eversley ,Ph.D. Rani
Return to Work after Breast Cancer Surgery			2001 (Cycle VII)	$625,000
	Women's Cancer Resource Center	Estrin ,BA Diane
Returning to Work and Quality of Life after Breast Cancer			1999 (Cycle V)	$86,147
	Women's Cancer Resource Center	Eversley ,Ph.D. Rani
Returning to Work and Quality of Life after Breast Cancer			1999 (Cycle V)	$86,147
	Women's Cancer Resource Center	Estrin ,BA Diane
Risk Factors and Breast Cancer Survival in Black/White Women			2009 (Cycle 15)	$89,996
	Beckman Research Institute of the City of Hope	Lu ,M.D. Yani
Risk Notification for Women at High Risk for Breast Cancer			1998 (Cycle IV)	$647,982
	Cancer Prevention Institute of California	Stewart ,Ph.D. Susan
Risk Notification for Women at High Risk for Breast Cancer			1998 (Cycle IV)	$647,982
	Cancer Prevention Institute of California	Bloom ,Ph.D. Joan
Risk Notification for Women at High Risk for Breast Cancer			1998 (Cycle IV)	$647,982
	Cancer Prevention Institute of California	Lee ,Ph.D. Marion
Rodent Model for Human Ductal Carcinoma in Situ			2001 (Cycle VII)	$100,000
	University of California, Berkeley	Nandi ,Ph.D. Satyabrata
Role of a DNA Damage Response Gene in Breast Cancer			1999 (Cycle V)	$70,000
	California Institute of Technology	Brown ,Ph.D. Eric
Role of BI-1 Protein in Breast Cancer Apoptosis			2004 (Cycle 10)	$87,424
	The Burnham Institute for Medical Research	Bailly-Maitre ,Ph.D. Beatrice
Role of Cell Division Asymmetry in Breast Cancer Stem Cells			2006 (Cycle 12)	$149,990
	University of California, San Francisco	Petritsch ,Ph.D. Claudia
Role of Chemokine Receptors in Breast Cancer Metastasis			1999 (Cycle V)	$41,311
	University of California, Los Angeles	Premack ,Ph.D. Brett
Role of Chromatin Regulator in Breast Cell Growth			2001 (Cycle VII)	$286,151
	University of California, Davis	Chen ,Ph.D. Hongwu
Role of Circadian Rhythm Gene Homolog PER3 in Breast Cancer			2009 (Cycle 15)	$45,000
	University of California, San Francisco	Jen ,M.D., Ph.D. Kuang-Yu
Role of Epimorphin and Progesterone in Breast Development			2002 (Cycle VIII)	$23,713
	Lawrence Berkeley National Laboratory	Bascom ,Ph.D. Jamie
Role of Estrogen in the Origin of Breast Cancer			1995 (Cycle I)	$300,000
	University of California, San Francisco	Kushner ,Ph.D. Peter
Role of Estrogen-modulated Protein AGR2 in Breast Cancer			2008 (Cycle 14)	$71,491
	University of California, Irvine	Geyfman ,B.S. Mikhail
Role of FGF10 in Early Mouse Mammary Gland Development			2003 (Cycle IX)	$446,400
	Childrens Hospital, Los Angeles	Bellusci ,Ph.D. Saverio
Role of Gamma-catenin in a Breast Cancer Mouse Model			1998 (Cycle IV)	$290,363
	The Burnham Institute for Medical Research	Reed ,M.D., Ph.D. John
Role of Id-2 in Breast Cancer and its Relationship to Id-1			2001 (Cycle VII)	$296,531
	California Pacific Medical Center Research Institute	Desprez ,Ph.D. Pierre-Yves
Role of IKKa in Mammary Gland Development			2001 (Cycle VII)	$563,696
	University of California, San Diego	Karin ,Ph.D. Michael
Role of Integrins in Lymphangiogenesis During Breast Cancer			2005 (Cycle 11)	$134,530
	University of California, San Diego	Susini ,Ph.D. Barbara
Role of L-Plastin in Breast Cancer			1995 (Cycle I)	$304,802
	University of California, San Francisco	Lin ,Ph.D. Ching-Shwun
Role of MMPs in Breast Tumor Initiation and Aggressiveness			2000 (Cycle VI)	$75,422
	Lawrence Berkeley National Laboratory	Fata ,Ph.D. Jimmie
Role of Oxidative DNA Damage to Breast Tumor Progression			2003 (Cycle IX)	$588,555
	Lawrence Livermore National Laboratory	Henderson ,Ph.D. Paul
Role of p14ARF in Metastatic Breast Cancer			2000 (Cycle VI)	$365,000
	Sidney Kimmel Cancer Center	Gjerset ,Ph.D. Ruth
Role of p53 in Irradiated Stroma and Mammary Carcinogenesis			2000 (Cycle VI)	$335,335
	Lawrence Berkeley National Laboratory	Barcellos-Hoff ,Ph.D. Mary Helen
Role of p68 in Breast Cancer			2009 (Cycle 15)	$165,339
	Lawrence Berkeley National Laboratory	Wang ,Ph.D. Daojing
Role of Pak Kinase in Breast Cancer Cell Cycle Progression			2002 (Cycle VIII)	$86,400
	Scripps Research Institute	Maroto ,Ph.D. Beatriz
Role of Rb Protein and Cell Cycle Defects in Breast Cancer			1998 (Cycle IV)	$283,376
	The Burnham Institute for Medical Research	Ely ,Ph.D. Kathryn
Role of Telomerase in Mammary Stem Cell Function			2005 (Cycle 11)	$236,379
	Stanford University	Artandi ,M.D., Ph.D. Steven
Role of the EphB4 Receptor Tyrosine Kinase in Breast Cancer			1999 (Cycle V)	$389,758
	The Burnham Institute for Medical Research	Pasquale ,Ph.D. Elena
Role of the POP1 Gene in Breast Cancer Genomic Stability			1999 (Cycle V)	$112,710
	Stanford University	Jackson ,Ph.D. Peter
Role of Vitamin D Receptor and PI3k Genes in Breast Cancer			2001 (Cycle VII)	$0
	University of California, San Francisco	Ylstra ,Ph.D. Bauke

S Top

Salivary Biomarkers for Early Detection of Breast Cancer			2010 (Cycle 16)	$150,000
	University of California, Los Angeles	Zhang ,Ph.D. Lei
Samoans and Breast Cancer: Evaluating a Theory-Based Program			1998 (Cycle IV)	$168,946
	University of California, Irvine	Mishra ,M.B.B.S., Ph.D Shiraz
Samoans and Cancer: Evaluation of a Culturally Appropriate P			1998 (Cycle IV)	$430,536
	National Office of Samoan Affairs	Luce ,M.S. Pat
SBP-1: A Novel Survivin Binding Protein in Breast Cancer			2001 (Cycle VII)	$32,050
	The Burnham Institute for Medical Research	Okada ,M.D., Ph.D. Kazuya
Science Literacy & Breast Cancer Clinical Trials Education			2007 (Cycle 13)	$121,402
	Vista Community Clinic	Riley ,M.A. Natasha
Science Literacy & Breast Cancer Clinical Trials Education			2007 (Cycle 13)	$44,003
	University of California, San Diego	Sadler ,Ph.D. M.B.A. Georgia
Selective Targeting of Breast Cancer with Radioiodide			2001 (Cycle VII)	$315,200
	Stanford University	Wapnir ,M.D. Irene
Sentinel Node Detection via Targeted Fluorescence			1998 (Cycle IV)	$41,259
	University of California, San Diego	Vera ,Ph.D. David
Serpentinites & the High Incidence of Breast Cancer in Marin			2004 (Cycle 10)	$10,000
	Marin Breast Cancer Watch	Barlow ,BSN, NP Janice
Serpentinites & the High Incidence of Breast Cancer in Marin			2004 (Cycle 10)	$10,000
	Marin Breast Cancer Watch	Fendorf ,Ph.D. Scott
Siah-family Genes: Effectors of p53 in Breast Cancer			1998 (Cycle IV)	$74,866
	The Burnham Institute for Medical Research	Matsuzawa ,Ph.D. Shu-ichi
Sister Survivor: African American Breast Cancer Coalition			2007 (Cycle 13)	$62,500
	Women of Essence	Harmon ,BA Gloria
Sister Survivor: African American Breast Cancer Coalition			2007 (Cycle 13)	$169,000
	Beckman Research Institute of the City of Hope	Ashing-Giwa ,Ph.D. Kimlin
Sister Survivor: Evaluating Best Practices in Social Support			2009 (Cycle 15)	$5,000
	Women of Color Breast Cancer Survivors Support Project	Tapp ,Carolyn
Sister Survivor: Evaluating Best Practices in Social Support			2009 (Cycle 15)	$5,000
	Beckman Research Institute of the City of Hope	Ashing-Giwa ,Ph.D. Kimlin
Smoking Effect on Pulmonary Metastasis from Breast Cancer			2001 (Cycle VII)	$74,968
	University of California, Davis	Murin ,M.D. Susan
Social Capital, Social Support and Long-Term Quality of Life			2006 (Cycle 12)	$67,540
	University of California, Berkeley	Petersen ,M.A., M.P.H. Dana
Social Support and Breast Cancer Control Among Latinas			1999 (Cycle V)	$27,628
	University of California, Los Angeles	Gallardo ,Psy.D. Nilsa
Social Support and QOL in Older Minority Women with BC			2006 (Cycle 12)	$62,169
	University of California, Los Angeles	Umezawa ,Ph.D. Yoshiko
Socioeconomics and Ethnicity Affect Tumor Endocrine Status			2004 (Cycle 10)	$42,117
	University of California, San Francisco	Bhatia ,M.D. Vinona
Sound Speed Tomography for Early Breast Cancer Detection			2009 (Cycle 15)	$74,325
	University of California, San Diego	Nebeker ,B.S. Jakob
South Asian Women with Breast Cancer: What are Their Needs?			2004 (Cycle 10)	$9,995
	University of California, Los Angeles	Bastani ,Ph.D. Roshan
South Asian Women with Breast Cancer: What are Their Needs?			2004 (Cycle 10)	$9,995
	University of California, Los Angeles	Surani ,B.S. Zul
South Asian Women with Breast Cancer: What are Their Needs?			2005 (Cycle 11)	$112,214
	University of California, Los Angeles	Surani ,B.S. Zul
South Asian Women with Breast Cancer: What are Their Needs?			2005 (Cycle 11)	$112,214
	University of California, Los Angeles	Glenn ,Ph.D. Beth
South Asian Women with Breast Cancer: What are Their Needs?			2005 (Cycle 11)	$112,214
	University of California, Los Angeles	Bastani ,Ph.D. Roshan
Southeast Asian Breast Health Navigation			2006 (Cycle 12)	$187,500
	Orange County Asian and Pacific Islander Community Alliance, Inc.	Kagawa-Singer ,Ph.D., R.N., M.N., M.A. Marjorie
Southeast Asian Breast Health Navigation			2006 (Cycle 12)	$187,500
	Orange County Asian and Pacific Islander Community Alliance, Inc.	Foo ,M.P.H., CHES Mary Anne
Soy Treatment for High-risk Women and DCIS Patients			2009 (Cycle 15)	$1,216,848
	University of Southern California	Wu ,Ph.D. Anna
Soy, DNA Methylation and Breast Cancer			2011 (Cycle 17)	$244,793
	University of Southern California	Wu ,Ph.D. Anna
Spatial Control of Matrix Proteolysis in Breast Cancer			1999 (Cycle V)	$340,383
	The Burnham Institute for Medical Research	Strongin ,Ph.D. Alex
Spatial Control of Matrix Proteolysis in Breast Cancer			1999 (Cycle V)	$0
	La Jolla Institute for Molecular Medicine	Strongin ,Ph.D. Alex
Specificity of Ras Signaling in Breast Cancer			1999 (Cycle V)	$236,706
	Scripps Research Institute	Jackson ,M.D. Janis
Src Signaling in Breast Cancer			2003 (Cycle IX)	$75,000
	University of California, Berkeley	Martin ,Ph.D. Steven
Statistical Techniques for Breast Biology & Cancer Research			2002 (Cycle VIII)	$792,845
	Lawrence Berkeley National Laboratory	Mian ,Ph.D. Saira
Stem Cells in Breast Cancer Metastasis			2004 (Cycle 10)	$313,559
	The Burnham Institute for Medical Research	Snyder ,M.D., Ph.D. Evan
Stem Cells in Breast Cancer Metastasis			2004 (Cycle 10)	$621,289
	Scripps Research Institute	Yates ,M.D., Ph.D. John
Stem Cells in Breast Cancer Metastasis			2004 (Cycle 10)	$621,289
	Scripps Research Institute	Felding-Habermann ,Ph.D. Brunhilde
Stem Cells of Molecularly Diverse ER-Negative Breast Cancers			2005 (Cycle 11)	$234,165
	Stanford University	Jeffrey ,M.D. Stefanie
Steroid Receptor Coactivators in Mammary Gland Development			2002 (Cycle VIII)	$377,450
	The Burnham Institute for Medical Research	Huang ,Ph.D. Shi
Stratifying DCIS Biopsies for Risk of Future Tumor Formation			2008 (Cycle 14)	$750,000
	University of California, San Francisco	Tlsty ,Ph.D. Thea
Stress Protein and Drug Resistance in Human Breast Cancer			2000 (Cycle VI)	$325,873
	University of Southern California	Lee ,Ph.D. Amy
Stroma Expression Patterns in Breast Cancer			2009 (Cycle 15)	$164,403
	Palo Alto Institute for Research & Education	West ,M.D., Ph.D. Robert
Structural Analysis of Cancer-Relevant BCRA2 Mutations			2005 (Cycle 11)	$100,000
	University of California, Davis	Stahlberg ,Ph.D. Henning
Structural Characterization of Aromatase			2005 (Cycle 11)	$67,543
	Beckman Research Institute of the City of Hope	Hong ,M.S. Yanyan
Structure and Function of the Bax Apoptosis Regulator			2002 (Cycle VIII)	$285,141
	The Burnham Institute for Medical Research	Marassi ,Ph.D. Francesca
Structure of EST1: A potential Drug Target for Breast Cancer			1996 (Cycle II)	$50,000
	University of California, Berkeley	Nelson ,Ph.D. Hillary
Studies of Tamoxifen/Toremifene DNA interactions in monkeys			1996 (Cycle II)	$75,000
	University of California, Davis	Hellmann-Blumberg ,Ph.D. Uta
Studies of Telomere Capping Dysfunction in Breast Cancer			2002 (Cycle VIII)	$117,712
	Lawrence Berkeley National Laboratory	Gilley ,Ph.D. David
Studies on the Role of the ER-beta in Breast Cancer			2000 (Cycle VI)	$59,102
	Lawrence Berkeley National Laboratory	Gilad ,Ph.D. Eli
Study of Inadequate Follow-up of Mammographic Abnormalities			1998 (Cycle IV)	$0
	Bay View-Hunter's Point Health Care Task Force	Coleman ,M.D. Arthur
Study of Inadequate Follow-up of Mammographic Abnormalities			1998 (Cycle IV)	$10,136
	University of California, San Francisco	Lee ,Ph.D. Marion
Study of Inadequate Follow-up of Mammographic Abnormalities			1998 (Cycle IV)	$10,136
	Bay View-Hunter's Point Health Care Task Force	Lee ,Ph.D. Marion
Study of Inadequate Follow-up of Mammography Abnormalities			1998 (Cycle IV)	$73,361
	San Francisco Department of Public Health	Evins ,Ph.D., M.P.H. Daramola
Study of the Apoptotic Phenotype as a Hallmark of Malignancy			2003 (Cycle IX)	$155,099
	University of California, San Francisco	Hylton ,Ph.D. Nola
Studying the Interaction of an Essiac Tea and Food Mutagen			2003 (Cycle IX)	$343,744
	Lawrence Livermore National Laboratory	Kulp ,Ph.D. Kristen
Substrate Profiling of Breast Cancer Related Proteases			2009 (Cycle 15)	$76,000
	Scripps Research Institute	Dix ,B.S. Melissa
Sulforaphane: Its Potential for Treatment of Breast Cancer			2006 (Cycle 12)	$65,415
	University of California, Santa Barbara	Azarenko ,M.A. Olga
Superfibronectin: A Novel Anti-Breast Cancer Agent			1997 (Cycle III)	$389,026
	The Burnham Institute for Medical Research	Pasqualini ,Ph.D. Renata
Suppressor Genes of Breast Cancer			2000 (Cycle VI)	$195,000
	The Burnham Institute for Medical Research	Huang ,Ph.D. Shi
Surrogate Markers for Green Tea			2004 (Cycle 10)	$99,811
	University of California, Los Angeles	Brooks ,M.D., FACS Mai
Surrogate Markers for Green Tea			2004 (Cycle 10)	$99,811
	University of California, Los Angeles	Rao ,M.D. Jian
Survival in de novo and Recurrent Metastatic Breast Cancer			2009 (Cycle 15)	$249,000
	Beckman Research Institute of the City of Hope	Pal ,M.D. Sumanta
Survivin: Target for Breast Cancer Brain Metastases			2005 (Cycle 11)	$242,854
	University of Southern California	Hofman ,Ph.D. Florence
Susceptibility to Breast Cancer: Dietary and Other Factors			1995 (Cycle I)	$299,567
	University of California, Irvine	Delfino ,M.D., Ph.D. Ralph
SXR: A Novel Target for Breast Cancer Therapeutics			1999 (Cycle V)	$58,132
	University of California, Irvine	Tabb ,Ph.D. Michelle
Symposium on the Intraductal Approach to Breast Cancer			2007 (Cycle 13)	$25,000
	Dr. Susan Love Research Foundation	Love ,M.D., M.B.A. Susan

T Top

T Cell immunotherapy of human breast cancer			1996 (Cycle II)	$197,305
	University of California, San Diego	Mitchell ,M.D. Malcolm
Tamoxifen Prevention: Is it Acceptable to Women at Risk?			1999 (Cycle V)	$321,373
	University of California, Davis	Melnikow ,M.D., M.P.H. Joy
Tamoxifen-Induced Endometrial Cell Transformation			2000 (Cycle VI)	$85,968
	Salk Institute for Biological Studies	Lu ,M.D., Ph.D. Zhimin
Targeted Chemoprevention in a Mouse Model for DCIS			2005 (Cycle 11)	$135,326
	University of California, Davis	Gregg ,M.D. Jeffrey
Targeted Chemotherapy to Treat Breast Cancer			2000 (Cycle VI)	$200,000
	University of California, San Francisco	Szoka ,Ph.D. Francis
Targeted Delivery of an Anti-breast Tumor Agent			2000 (Cycle VI)	$684,291
	University of Southern California	Markland ,Ph.D. Francis
Targeted Delivery of an Anti-breast Tumor Agent			2000 (Cycle VI)	$684,291
	University of Southern California	Fujii ,Ph.D. Gary
Targeted Delivery of an Anti-breast Tumor Agent			2000 (Cycle VI)	$684,291
	University of Southern California	Kasahara ,M.D., Ph.D. Noriyuki
Targeted gene therapy using anti-pl85HER2 immunoliposomes			1996 (Cycle II)	$205,410
	University of California, San Francisco	Park ,M.D. John
Targeted search for new transcription factors in breast cell			1996 (Cycle II)	$61,231
	Lawrence Berkeley National Laboratory	Lin ,Ph.D. Claudia
Targeting Brain Metastasis with a Cell-based Approach			2010 (Cycle 16)	$284,850
	Scripps Research Institute	Felding-Habermann ,Ph.D. Brunhilde
Targeting Breast Cancer Blood Vessels			1999 (Cycle V)	$363,905
	Sidney Kimmel Cancer Center	Schnitzer ,M.D. Jan
Targeting Breast Cancer Using Diphtheria Toxin			1996 (Cycle II)	$375,052
	Salk Institute for Biological Studies	Choe ,Ph.D. Senyon
Targeting Breast Tumor Stem Cells with Cell Cycle Inhibitors			2010 (Cycle 16)	$76,000
	University of California, San Francisco	Huskey ,BA Noelle
Targeting DNA Repair Function of Breast Cancer Stem Cells			2009 (Cycle 15)	$284,660
	Scripps Research Institute	Wu ,Ph.D. Xiaohua
Targeting Drug Resistant Breast Cancer by microRNAs			2010 (Cycle 16)	$100,000
	University of California, Los Angeles	Hu ,Ph.D. Hailiang
Targeting Estrogen Receptors to Mouse Mammary Epithelium			2002 (Cycle VIII)	$36,027
	University of California, San Francisco	Price ,M.D. Richard
Targeting Histone Acetyltransferase in Triple Negative BC			2011 (Cycle 17)	$273,000
	Torrey Pines Institute for Molecular Studies	Gjerset ,Ph.D. Ruth
Targeting MYC in Human Breast Cancer			2009 (Cycle 15)	$90,000
	University of California, San Francisco	Horiuchi ,Ph.D. Dai
Targeting of DNA Methylation in Mammary Epithelial Cells			2004 (Cycle 10)	$87,291
	Salk Institute for Biological Studies	Liston ,Ph.D. David
Targeting of Tumor-Promoting Galectins in Breast Cancer			2001 (Cycle VII)	$182,500
	Sidney Kimmel Cancer Center	Huflejt ,Ph.D. Margaret
Targeting Prolactin as a Novel Treatment for Breast Cancer			2011 (Cycle 17)	$150,000
	University of California, Riverside	Walker ,Ph.D. Ameae
Targeting T Cells to Breast Cancer			1997 (Cycle III)	$388,050
	The Burnham Institute for Medical Research	Smith ,Ph.D. Jeffrey
Targeting the EphB4 Receptor to Inhibit Breast Tumor Growth			2001 (Cycle VII)	$184,576
	The Burnham Institute for Medical Research	Pasquale ,Ph.D. Elena
Targeting Tissue Factor in Breast Cancer			2007 (Cycle 13)	$89,600
	Scripps Research Institute	Schaffner ,Ph.D. Florence
Targets of B Cell Infiltrate in Medullary Breast Cancer			1998 (Cycle IV)	$279,890
	Scripps Research Institute	Ditzel ,M.D., Ph.D Henrik
Tea, Genes and Their Interactions on Breast Cancer			2004 (Cycle 10)	$1,610,872
	University of Southern California	Wu ,Ph.D. Anna
Telephone-Based Decision Support for Rural Patients			2006 (Cycle 12)	$310,914
	University of California, San Francisco	Belkora ,Ph.D. Jeffrey
Telephone-Based Decision Support for Rural Patients			2006 (Cycle 12)	$361,358
	Mendocino Cancer Resource Center	O'Donnell ,Sara
Telomerase, Mammary Stem Cells, and Breast Cancer			2007 (Cycle 13)	$360,277
	Stanford University	Artandi ,M.D., Ph.D. Steven
Telomerase: A Factor for Early Detection of Breast Cancer			1995 (Cycle I)	$224,149
	Geron Corporation	Kim ,Ph.D. Nam Woo
Telomere Clustering is Lost in Mammary Epithelial Tumors			2001 (Cycle VII)	$79,999
	Lawrence Berkeley National Laboratory	Kaminker ,Ph.D. Patrick
Telomere Dynamics during Breast Development			2001 (Cycle VII)	$157,189
	Lawrence Berkeley National Laboratory	Kim ,Ph.D. Sahn-Ho
TGF-B3 and small GTPases in Invasive Breast Cancer			2000 (Cycle VI)	$323,925
	Childrens Hospital, Los Angeles	Kaartinen ,Ph.D. Vesa
TGF-Beta Receptor Signaling and Breast Cancer			1998 (Cycle IV)	$362,691
	Lawrence Berkeley National Laboratory	Luo ,Ph.D. Kunxin
The Androgen Receptor and Mammographic Density			2002 (Cycle VIII)	$59,868
	University of Southern California	Osth-Lillie ,M.S. Elizabeth
The Breast Cancer Experience of Slavic Women			2006 (Cycle 12)	$166,431
	University of California, Davis	Paterniti ,Ph.D. Debora
The Breast Cancer Experience of Slavic Women			2006 (Cycle 12)	$166,431
	University of California, Davis	Romaso ,Roman
The Breast Care Center: Innovative Care for the Underserved			1997 (Cycle III)	$267,981
	Cancer Prevention Institute of California	Harness ,M.D. Jay
The Breast Tumor Suppressor Function of Hyaluronidase			1995 (Cycle I)	$302,120
	University of California, San Francisco	Stern ,M.D. Robert
The Control of Breast Cancer Cell Death			2000 (Cycle VI)	$306,149
	Stanford University	Mochly-Rosen ,Ph.D. Daria
The Cost of Breast Cancer in California			2003 (Cycle IX)	$315,198
	University of California, San Francisco	Max ,Ph.D. Wendy
The Detailed Structure of a Model Breast Cancer Genome			2002 (Cycle VIII)	$149,590
	University of California, San Francisco	Collins ,Ph.D. Colin
The Efficacy of a Retreat for Low-Income Women with Breast C			1997 (Cycle III)	$0
	Charlotte Maxwell Complementary Clinic	Levenberg ,B.S.N. Shoshana
The Efficacy of Retreat for Low-Income Women with Breast Can			1997 (Cycle III)	$87,499
	California Pacific Medical Center Research Institute	Levine ,Ph.D., M.P.H. Ellen
The Functional Implications of Taxane-induced Neuropathy			2004 (Cycle 10)	$33,937
	University of California, San Francisco	Edwards Wampler ,B.H.S. Meredith
The Functions of BRCA2 in Repairing DNA Damage			2001 (Cycle VII)	$485,757
	Lawrence Berkeley National Laboratory	Lio ,Ph.D. Yi-Ching
The Hygiene Hypothesis and Breast Cancer Risk			2003 (Cycle IX)	$366,955
	Cancer Prevention Institute of California	Clarke Dur ,Ph.D. Christina
The IGF Pathway & Breast Cancer Risk in African Americans			2003 (Cycle IX)	$422,467
	University of California, Irvine	Neuhausen ,Ph.D. Susan
The Impact of Structure on Quality of Breast Cancer Care			2001 (Cycle VII)	$891,916
	University of California, Los Angeles	Kahn ,M.D. Katherine
The Importance of Growth Inhibitory Signals in Normal Breast			2002 (Cycle VIII)	$150,000
	University of California, Los Angeles	Wilson ,Ph.D. Cindy
The Invasive Nature of Epithelial Breast Cancer Cells			1995 (Cycle I)	$105,837
	Lawrence Berkeley National Laboratory	Desprez ,Ph.D. Pierre-Yves
The Invasive Nature of Epithelial Breast Cancer Cells			1995 (Cycle I)	$269,852
	California Pacific Medical Center Research Institute	Desprez ,Ph.D. Pierre-Yves
The PTEN/Akt Pathway in Ductal Carcinoma In Situ			2001 (Cycle VII)	$99,604
	Cedars-Sinai Medical Center	Bose ,M.D. Shikha
The Regulation of p53 Activity in Breast Cancer			1999 (Cycle V)	$51,393
	University of California, San Diego	Xu ,Ph.D. Yang
The Regulation of SATB1 in Metastatic Breast Cancer			2009 (Cycle 15)	$36,379
	Lawrence Berkeley National Laboratory	Friesenhahn ,Ph.D. Laurie
The Relationship of BRCA1 and HMGA2 in Breast Cancer			2007 (Cycle 13)	$36,704
	University of California, Irvine	Tsai ,B.S. Connie
The Role of a Newly Discovered Neuregulin in Breast Cancer			1998 (Cycle IV)	$87,472
	Scripps Research Institute	Lai ,Ph.D. Cary Hsing Chao
The Role of a Novel Estrogen Receptor in Breast Cancer			1997 (Cycle III)	$231,039
	Lawrence Berkeley National Laboratory	Lupu ,Ph.D. Ruth
The Role of ANCCA in Tamoxifen Resistant Breast Cancer			2010 (Cycle 16)	$89,600
	University of California, Davis	Andrews ,Ph.D. Nicolas
The Role of B-Myb in Human Breast Cancer Progression			2005 (Cycle 11)	$156,106
	Stanford University	Lipsick ,M.D.,Ph.D. Joseph
The Role of BRCA1 in Nucleotide Excision Repair			2001 (Cycle VII)	$85,968
	Stanford University	Hartman ,M.D. Anne-Renee
The Role of Chk1 in Breast Cancer DNA Damage Repair			2006 (Cycle 12)	$80,740
	Scripps Research Institute	Scorah ,Ph.D. Jennifer
The Role of Clim Proteins in Breast Cancer			2010 (Cycle 16)	$37,961
	University of California, Irvine	Verma ,Ph.D. Suman
The Role of EGF Variant mLEEK and Grp78 in Breast Cancer			2009 (Cycle 15)	$241,380
	Stanford University	Wong ,M.D. Albert
The Role of Estrogen Receptor in Endocrine Resistance			2009 (Cycle 15)	$76,000
	Beckman Research Institute of the City of Hope	Chan ,B.S. Hei
The Role of Estrogen-Related Receptors in Breast Cancer			2006 (Cycle 12)	$278,106
	Scripps Research Institute	Kralli ,Ph.D. Anastasia
The Role of Gli3 in Mouse Embryonic Mammary Gland Formation			2004 (Cycle 10)	$90,000
	Childrens Hospital, Los Angeles	Veltmaat ,Ph.D. Jacqueline
The Role of IL-8 and its Receptors in Angiogenesis			2000 (Cycle VI)	$149,699
	La Jolla Institute for Molecular Medicine	Schraufstatter ,M.D. Ingrid
The Role of LMO4 in Breast Cancer			2005 (Cycle 11)	$135,000
	University of California, Irvine	Yu ,Ph.D. Zhengquan
The Role of MAR-Binding Protein in Breast Cancer			1995 (Cycle I)	$328,849
	Lawrence Berkeley National Laboratory	Kohwi-Shigematsu ,Ph.D. Terumi
The Role of MAR-Binding Protein in Breast Cancer			1995 (Cycle I)	$223,201
	The Burnham Institute for Medical Research	Kohwi-Shigematsu ,Ph.D. Terumi
The Role of Matrix Metalloproteinase 13 in Breast Cancer			2002 (Cycle VIII)	$80,000
	University of California, San Francisco	Egeblad ,Ph.D. Mikala
The Role of Meltrin-a in Breast Cancer-Associated Bone Loss			1997 (Cycle III)	$75,600
	The Burnham Institute for Medical Research	Le Calvez ,Ph.D. Hervé
The Role of microRNAs in Triple-Negative Breast Cancer			2010 (Cycle 16)	$89,600
	University of California, San Francisco	Kusdra ,Leonard
The Role of N-CoR During Normal Mammary Gland Development			2000 (Cycle VI)	$75,583
	University of California, San Diego	Baek ,Ph.D. Sung Hee
The Role of PAK2 in Breast Cancer Cell Death			1997 (Cycle III)	$529,149
	Scripps Research Institute	Bokoch ,Ph.D. Gary
The Role of Plant Estrogens in Reducing Breast Cancer Risk			1995 (Cycle I)	$406,668
	Cancer Prevention Institute of California	Horn-Ross ,Ph.D. Pamela
The Role of Podosomes in Breast Cancer Metastasis			2006 (Cycle 12)	$134,618
	The Burnham Institute for Medical Research	Blouw ,Ph.D. Barbara
The Role of PTEN in Progression of Ductal Carcinoma in situ			2002 (Cycle VIII)	$305,507
	Cedars-Sinai Medical Center	Bose ,M.D. Shikha
The Role of Serine and Metallo-Hydrolases in Breast Cancer			2006 (Cycle 12)	$72,275
	Scripps Research Institute	Niessen ,M.S. Sherry
The Role of SGK in Breast Cancer Proliferation			2001 (Cycle VII)	$85,212
	Scripps Research Institute	Hayashi ,M.D., Ph.D. Masaaki
The Role of the BMK1-MEKK3 Pathway in Breast Cancer			2000 (Cycle VI)	$64,152
	Scripps Research Institute	Chao ,Ph.D. Ta-Hsiang
The Role of the ECM in Breast Cancer DNA Damage Repair			2005 (Cycle 11)	$250,560
	Lawrence Berkeley National Laboratory	Davalos ,Ph.D. Albert
The Role of Twist1 in Epithelial-mesenchymal Transition			2010 (Cycle 16)	$90,000
	University of California, San Diego	Tsai ,Ph.D. Jeff
The Shp-2 Tyrosine Phosphatase in Breast Tumor Migration			1999 (Cycle V)	$75,600
	The Burnham Institute for Medical Research	Sun ,Ph.D. YingQing
Three-Dimensional Modeling of Breast Cancer Progression			2002 (Cycle VIII)	$329,901
	Lawrence Berkeley National Laboratory	Ortiz de Solorzano ,Ph.D. Carlos
Thrombosis for Anti-angiogenic Therapy of Breast Cancer			2000 (Cycle VI)	$199,633
	University of California, Irvine	Su ,Ph.D. Min-Ying (Lydia)
Tibetan Medicine for Advanced Breast Cancer			1996 (Cycle II)	$53,231
	University of California, San Francisco	Tripathy ,M.D. Debasish
Timing of Breast Cancer Surgery, Menstrual Cycle & Prognosis			1998 (Cycle IV)	$506,070
	University of California, San Diego	Klonoff-Cohen ,Ph.D. Hillary
Timing of Breast Cancer Surgery, Menstrual Cycle & Prognosis			1998 (Cycle IV)	$506,070
	University of California, San Diego	Shau ,Ph.D. Hungyi
Timing of Breast Cancer Surgery, Menstrual Cycle & Prognosis			1998 (Cycle IV)	$506,070
	University of California, San Diego	Chang ,M.D., Ph.D. Helena
TIMP-3, an early indicator of breast cancer?			1996 (Cycle II)	$184,537
	University of California, San Francisco	Hawkes ,Ph.D. Susan
Topoisomerase-IIa as a Predictor of Anthracycline Response			2006 (Cycle 12)	$244,499
	University of Southern California	Press ,M.D., Ph.D. Michael
Topoisomerase-IIa as a Predictor of Anthracycline Response			2008 (Cycle 14)	$407,500
	University of Southern California	Press ,M.D., Ph.D. Michael
Towards Highly Effective Inactivation of HER2-HER3 Signaling			2010 (Cycle 16)	$745,357
	University of California, San Francisco	Moasser ,M.D. Mark
TR3-based Peptides for Apoptosis in Breast Cancer			2002 (Cycle VIII)	$380,825
	The Burnham Institute for Medical Research	Zhang ,Ph.D. Xiao-Kun
TRAF-regulated Signal Transduction in Breast Cancer			1997 (Cycle III)	$75,600
	The Burnham Institute for Medical Research	Zapata ,Ph.D. Juan
Translational Proteomics of Normal to Benign Breast Disease			2003 (Cycle IX)	$188,044
	John Wayne Cancer Institute	Hoon ,MSc, Ph.D. David
Translational Proteomics of Normal to Benign Breast Disease			2003 (Cycle IX)	$188,044
	John Wayne Cancer Institute	Giuliano ,M.D. Armando
Translational Proteomics of Normal to Benign Breast Disease			2003 (Cycle IX)	$188,044
	John Wayne Cancer Institute	Wilson ,M.D. Lori
Trask, a Candidate Breast Cancer Metastasis Protein			2007 (Cycle 13)	$90,000
	University of California, San Francisco	Wong ,Ph.D. Ching Hang
Treating BC Brain Metastases with Cytotoxic Lymphocytes			2008 (Cycle 14)	$105,538
	Torrey Pines Institute for Molecular Studies	Mueller ,Ph.D. Barbara
Treating BC Brain Metastases with Cytotoxic Lymphocytes			2008 (Cycle 14)	$186,496
	Sidney Kimmel Cancer Center	Mueller ,Ph.D. Barbara
Treating Insomnia with CBT in Women with Breast Cancer			2005 (Cycle 11)	$73,218
	University of California, San Diego	Fiorentino ,Ph.D. Lavinia
Trypsin-like Proteases as Metastatic Agents in Breast Cancer			2001 (Cycle VII)	$295,893
	University of California, Riverside	DeFea ,Ph.D. Kathryn
Tumor Suppression by Dystroglycan in Breast Epithelial Cells			2001 (Cycle VII)	$302,190
	California Pacific Medical Center Research Institute	Muschler ,Ph.D. John
Tumor Suppression by Dystroglycan in Breast Epithelial Cells			2001 (Cycle VII)	$9,624
	Lawrence Berkeley National Laboratory	Muschler ,Ph.D. John
Tumor Suppression by Dystrogylcan in Breast Epithelial Cells			2000 (Cycle VI)	$181,347
	Lawrence Berkeley National Laboratory	Muschler ,Ph.D. John
Tumor Suppressor 14-3-3sigma in Breast Cancer Progression			2008 (Cycle 14)	$62,434
	Lawrence Berkeley National Laboratory	Boudreau ,B.Sc. Aaron
Twist Activation in Breast Cancer Metastasis			2006 (Cycle 12)	$150,000
	University of California, San Diego	Yang ,Ph.D. Jing
Two candidate breast cancer genes on chromosome			1995 (Cycle I)	$481,843
	Childrens Hospital, Los Angeles	Groffen ,Ph.D. John

U Top

UCLA Biomedical Physics Graduate Training in Breast Cancer			1996 (Cycle II)	$305,847
	University of California, Los Angeles	Kimme-Smith ,Ph.D. Carolyn
UCLA Biomedical Physics Graduate Training in Breast Cancer			1999 (Cycle V)	$187,981
	University of California, Los Angeles	Cooper ,Ph.D. Virgil
Ultrasound Computed Tomography for Breast Lesion Detection			1995 (Cycle I)	$45,382
	University of California, San Diego	Leopold ,M.D. George
Underserved Women with Breast Cancer at End of Life			2007 (Cycle 13)	$437,845
	University of California, San Francisco	Adler ,Ph.D. Shelley
Underserved Women with Breast Cancer at End of Life			2004 (Cycle 10)	$0
	Charlotte Maxwell Complementary Clinic	Burns ,MS, BA, Beverly
Underserved Women with Breast Cancer at End of Life			2005 (Cycle 11)	$56,832
	University of California, San Francisco	Adler ,Ph.D. Shelley
Underserved Women with Breast Cancer at End of Life			2007 (Cycle 13)	$169,653
	Charlotte Maxwell Complementary Clinic	Stone ,Kendra
Underserved Women with Breast Cancer at End of Life			2005 (Cycle 11)	$53,346
	Charlotte Maxwell Complementary Clinic	Burns ,MS, BA, Beverly
Underserved Women with Breast Cancer at End of Life			2004 (Cycle 10)	$10,000
	University of California, San Francisco	Adler ,Ph.D. Shelley
Understanding Aging Effects in the Breast			2002 (Cycle VIII)	$448,730
	Lawrence Berkeley National Laboratory	Krtolica ,Ph.D. Ana
Understanding Breast Cancer Cell Metastasis to Bone			1998 (Cycle IV)	$436,722
	The Burnham Institute for Medical Research	Narisawa ,Ph.D. Sonoko
Understanding Breast Cancer Screening in Filipino Women			1995 (Cycle I)	$50,057
	University of California, Los Angeles	Maxwell ,DrPH Annette
Understanding Herceptin Resistance with Dual Function Array			2003 (Cycle IX)	$49,612
	University of California, San Francisco	Ching ,Ph.D. Tsui-Ting
Understanding Tamoxifen - A Drug for Breast Cancer			1995 (Cycle I)	$225,000
	University of California, San Francisco	Webb ,Ph.D. Paul
Understanding Telomere Dynamics in the Breast			2002 (Cycle VIII)	$681,564
	Stanford University	Artandi ,M.D., Ph.D. Steven
Understanding the Role of GATA3 in Breast Cancer			2009 (Cycle 15)	$38,000
	University of California, San Francisco	Chou ,B.S. Jonathan
Unique Genes Expressed in Cancer Cells			1999 (Cycle V)	$149,850
	University of California, Riverside	Byus ,Ph.D. Craig
Upregulation of BRCA1 as a Cancer Preventive Strategy			2000 (Cycle VI)	$610,319
	University of Southern California	Hill ,Ph.D. Colin
USC/NCCC Breast Cancer Research Training Program			2002 (Cycle VIII)	$266,759
	University of Southern California	Press ,M.D., Ph.D. Michael
USC/Norris Breast Cancer Research Training Program			1995 (Cycle I)	$301,138
	University of Southern California	Ross ,M.D. Ronald
Using Microarrays to Estimate Breast Cancer Risk			2002 (Cycle VIII)	$34,233
	Stanford University	Ekstrand ,M.D., Ph.D. Bradley
Using Scientific Text to Identify Breast Cancer Risk-Factors			2002 (Cycle VIII)	$29,136
	University of California, Irvine	Blake ,M.S. Catherine

V Top

Vascular Targeting Therapy for Breast Cancer			2006 (Cycle 12)	$288,728
	Sidney Kimmel Cancer Center	Deisseroth ,M.D., Ph.D. Albert
Vitamin D & Genetics of Vitamin D Receptor in Breast Cancer			1995 (Cycle I)	$80,976
	University of Southern California	Ingles ,DrPH Sue Ann
Vitamin D and Breast Cancer in Obesity: Therapeutic Trials			2011 (Cycle 17)	$1,169,860
	Stanford University	Feldman ,M.D. David
Vitamin D and Breast Cancer Prevention: Cell Death vs Growth			1995 (Cycle I)	$70,000
	Lawrence Berkeley National Laboratory	Weaver ,Ph.D. Valerie
Vitamin D and Breast Cancer Survival			2010 (Cycle 16)	$220,495
	Cancer Prevention Institute of California	Wang ,M.D. Wei
Vitamin D Receptor Gene and Breast Cancer Risk			1997 (Cycle III)	$241,803
	University of Southern California	Ingles ,DrPH Sue Ann

W Top

Weight Loss in Public Hospital Breast Cancer Patients			2002 (Cycle VIII)	$140,541
	LA Biomedical Research Institute at Harbor-UCLA Medical Center	Chlebowski ,M.D., Ph.D. Rowan
Why do 70% of Breast Cancers Metastasize to Bone?			1996 (Cycle II)	$97,407
	The Burnham Institute for Medical Research	Millan ,Ph.D. Jose
Why Does Normal Cell Death Not Occur in Breast Cancer?			1996 (Cycle II)	$38,088
	University of California, San Diego	Liu ,Ph.D. Zheng-gang
Wnt Signaling in Breast Cancer: Translational Studies			2000 (Cycle VI)	$328,129
	University of California, Irvine	Waterman ,Ph.D. Marian
Wnt Signaling in Breast Cancer: Translational Studies			2000 (Cycle VI)	$328,129
	University of California, Irvine	Holcombe ,M.D. Randall
Wnt Signaling in Breast Cancer: Translational Studies			2000 (Cycle VI)	$328,129
	University of California, Irvine	Marsh ,J. Lawrence
Women with Breast Cancer: Quality of Life and Diet Adherence			2001 (Cycle VII)	$164,427
	University of California, San Diego	Bardwell ,Ph.D. Wayne

X Top

Xenoestrogens and Breast Cancer in African American Women			1996 (Cycle II)	$254,069
	Public Health Institute	Reynolds ,Ph.D. Peggy
Xenoestrogens and Genetic Damage in Breast Cancer			1995 (Cycle I)	$159,053
	SRI International	Robertson Creek ,Ph.D., MPH Moire

Y Top

Young Breast Cancer Survivors: Ten Years Later			2004 (Cycle 10)	$933,032
	University of California, Berkeley	Bloom ,Ph.D. Joan

Z Top

Zinc Finger proteins as therapeutic agents for breast			1996 (Cycle II)	$43,440
	Scripps Research Institute	Liu ,Ph.D. Qiang